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ABSTRACTS for the immune system. For example, efflux systems relevant to neuro-stage of the disease; they have been under L-dopa treatment for some time and remain under medication after transplantation. Studies have degenerative diseases such as Alzheimer's disease (AD) are altered by immune activation. Low-density lipoprotein receptor-related protein 1 previously looked at the role of L-dopa on transplanted neuron survival but only in syngeneic models, while patients will receive donor (LRP-1) at the BBB pumps amyloid beta peptide (ABP) out of the brain. According to the neurovascular hypothesis, LRP-1 activity is tissue from allogeneic sources. Additionally previous work has not considered the role of prior exposure to L-dopa versus posttransplanta-deficient in patients with AD and in animal models of AD. Antisense knockdown of LRP-1 leads to decreased efflux of ABP, increased tion administration only. In this study, we investigated the effect that chronic L-dopa treatment has on the survival and the function of the brain levels of ABP, and cognitive impairments. LRP-1 itself is increasingly oxidized in the brains of patients with AD. Lipopolysac-graft. 6-OHDA-lesioned rats were treated daily with either saline or L-dopa (10 mg/kg, coadministrated with 15 mg/kg benserazide) for charide (LPS) decreases ABP efflux from brain and the antioxidant N-acetylcysteine reverses this effect. This suggests that neuroinflam-the 8 weeks prior to and/or the 8 weeks following transplantation of ventral mesencephalon (either rat e14 or mouse e12). The animals mation could result in LRP-1 oxidation and increased ABP retention, thus fostering the progression of AD. In these and other ways, the were assessed for functional recovery and dyskinesia at regular intervals. No spontaneous GID was observed "off" drug in any group. The BBB interacts with neuroinflammation to affect the course of neurodegenerative diseases. different treatment regimes did not affect functional recovery but influenced the AIM score when the animals were assessed posttransplantation following L-dopa administration. We show that L-dopa Modulation of the Innate Immune System in Aging as a Target treatment is not detrimental to the survival and function of the graft for Increasing Endogenous Repair and Synaptic Plasticity and may even be beneficial. Histological analysis will examine the consequences of L-dopa administration on graft integrity and be P. C. Bickford* † related to animals' performances on behavioral assessments. This finding is of significant clinical relevance, as questions remain about the *James A. Haley Veterans' Administration Hospital Research selection of patients for transplantation, L-dopa administration may be Service, Tampa, FL, USA key to the anticipated outcome. †Center of Excellence for Aging and Brain Repair, Department of Neurosurgery and Brain Repair, University of South Florida Morsani Ketogenic Diet Improves Motor Performance but not Cognition College of Medicine, Tampa, FL, USA in Mouse Models of Alzheimer's Disease Changes in innate immune function are early and critical events in brain aging. Importantly, neurodegenerative diseases emerge and are M. Brownlow,* † L. Benner,* † D. D'Agostino,* † M. N. Gordon,* † and D. Morgan* † exacerbated with this context. Functional changes in microglial phenotype can lead to dysregulation of proinflammatory molecules that initiates neuronal dysfunction and reduced synaptic plasticity in the aged *Byrd Alzheimer's Research Institute, University of South Florida, Tampa, FL, USA brain. Microglia in young and nondiseased brain are constantly surveying the environment for "danger" signals. In this so-called "resting" †Department of Molecular Pharmacology and Physiology, University of South Florida, Tampa, FL, USA phenotype, microglia are not static, but quite active. Neurons produce signaling molecules [e.g., CX3CL1 (fractalkine)] that turn off produc-Interest is emerging in the involvement of dietary manipulations tion of induced nitric oxide synthase (iNOS), interleukin-1β (IL-1β), and their pharmacological outcomes in neurodegenerative diseases. tumor necrosis factor-α (TNF-α) among other proinflammatory mole-Recent studies suggest that Alzheimer's disease (AD) patients display cules. With aging, we and others have demonstrated that there is a an energy imbalance with brain hypometabolism and/or mitochondrial decrease in the production of these "calming" signals, which leads to deficits. Ketogenic diets (KD), widely investigated in the treatment a disrupted regulation of microglia in the brain. Additional changes and prevention of seizures, have been suggested to bypass metabolic with age in the peripheral immune system also influence the brain as deficits present in AD brains by providing ketone bodies as an alternaserum proteins and peripheral immune cells communicate with the tive fuel. We investigated the effects of a ketogenic diet on two mouse brain, and may also contribute to the disruption of "resting" microglial models of AD. Five-month-old amyloid precursor protein/presenilin 1 phenotype. These extrinsic factors have been shown to have a negative (APP/PS1) and Tg4510 mice were kept on either a KD or a control impact on the brain and the neurogenic niche. Over the years we have (NIH-31) diet for 3 months, and then submitted to a battery of behavexamined a number of ways to modulate the innate immune system ioral tests. Body weight and food intake were monitored throughout including stem cells, nutritional supplements, and chemokine treatment. the study; blood was collected at 4 weeks and at the end of the study for ketone and glucose assessments. Both APP/PS1 and Tg4510 mice weigh less than nontransgenic mice, despite an increased food intake.
Effect of L-Dopa Treatment on the Efficacy of Cell Therapy
Interestingly, the ketogenic diet did not affect these differences in in a Rat Model of Parkinson's Disease body weight or food consumption. We found that both mouse models of AD presented hyperactivity, compared to nontransgenic, age-L. S. J. Breger,* † S. B. Dunnett, † and E. L. Lane* matched controls, and that this effect was not prevented by KD. This was measured by both open field and y-maze tests. Mice kept on KD *School of Pharmacy & Pharmaceutical Sciences, Cardiff University, performed significantly better on an endurance trial in the rotarod Cardiff, UK compared to mice on the control diet. Only a genotype effect was †Brain Repair Group, School of Biosciences, Cardiff University, observed in the radial arm water maze test with no significant differ-Cardiff, UK ences between diets. Brain tissue was collected at the end of behav-The dopamine precursor L-dopa can alleviate the motor dysfuncioral testing, and analysis of amyloid, tau, and microglial markers is tion associated with the degenerative condition Parkinson's disease ongoing. These initial data suggest that the metabolic rate of the trans-(PD) but unfortunately long-term treatment is associated with major genic mice is considerably greater than the nontransgenic mice and side effects: patients develop abnormal involuntary movements (AIM) that ketogenic diet may play an important role in motor performance called dyskinesia. An alternative approach, currently under investigain mice. tion in a new clinical trial, is the replacement of the lost striatal dopa-Research supported by IIRG-10-174448. minergic innervation by transplantation of fetal ventral mesencephalon (VM) dopaminergic precursor cells. Despite showing benefits in some patients, this technique has been associated with the appearance of motor complications following transplantation in the absence of drug treatment, so-called graft-induced dyskinesia (GID). The causes of this variability and side effects in cell therapy efficacy are still to be determined. Patients entering clinical trials are typically at an advanced growth factors on brain repair in chronic stroke. These findings would
We have previously shown that transplanted astrocytes derived from bone morphogenetic protein-treated embryonic glial restricted help in developing a new therapeutic strategy to treat chronic stroke.
precursors (GDAs BMP ) can suppress scar formation, support axon Committed Human Neural Stem Cell-Derived Dopaminergic regeneration, enhance neuroprotection, and promote robust functional Neurons Differentiate in Nonhuman Primate Model recovery when transplanted to acute spinal cord injuries in adult rats of Parkinson's Disease (see http://jbiol.com/content/5/3/7). To test the ability of these cells to promote recovery after long-term chronic spinal cord injury, GDAs BMP D. Dai,* J. Bernitz,* D. E. Redmond, Jr., † E. Y. Snyder,* or undifferentiated glial restricted precursors (GRPs) were transplanted and M. M. Daadi* ‡ § into the spinal cords of adult rats at time points of 1 or 8 months after unilateral transection injury of the cervical dorsolateral funiculus at *Program in Stem Cell & Regenerative Biology, Sanford-Burnham the C3/C4 spinal level. This injury caused long-lasting, stable locomo-Medical Research Institute, La Jolla, CA, USA tor deficits as measured by the horizontal ladder test (skilled task) and †Departments of Psychiatry and Neurosurgery, Yale University the CatWalk apparatus (unskilled task). Animals that received trans-School of Medicine, New Haven, CT, USA plants of GDAs BMP at either 1 or 8 months after spinal cord injury ‡Department of Neurosurgery, Stanford Institute for Neuroshowed robust improvements in locomotor function. In contrast, the Innovation and Translational Neurosciences, Stanford University horizontal ladder performances of rats that received transplants of School of Medicine, Stanford, CA, USA undifferentiated GRPs at either 1 or 8 months after injury were not §Molecular Medicine Research Institute, Sunnyvale, CA, USA different from those of media-injected injury control animals at all time points posttreatment. Transplantation of GDAs BMP , but not GRPs, Optimal therapeutic human neural stem cells (hNSCs) for Parkinalso promoted a 67% increase in synapsin-1 immunodensity, an indison's disease (PD) should be scalable, express midbrain identity, cator of increased synaptic plasticity, within cervical motor neuron engraft in animal models of PD, and differentiate into functional dopapools. The results of our present study are therefore consistent with minergic neurons, ideally the A9 type, that appropriately reinnervate our previous comparisons of the effects of transplanted rat and human the striatum in PD. The search for such a cell line continues. In the GDAs versus undifferentiated GRP cells in acute spinal cord-injured present study, we have successfully and efficiently directed a fetal rats and provide support for the development of GDAs BMP transplanta-hNSC towards the midbrain DA identity. The hNSCs were perpetuated tion as a therapy for the long-term chronically injured human spinal cord. for over 25 passages in defined media containing epidermal growth Funding: Private donations from the SCI community to S.J.A.D.; factor (EGF), fibroblast growth factor (FGF), and leukemia inhibitory Carlson Stem Cell Trust to C.J.P. and M.N.; NYS DOH Spinal Cord factor (LIF). Their midbrain identity was revealed by the expression Injury Research C023691 to M.M.-P. of the transcription factors Nurr1 and Pitx3. When induced to differentiate by growth factor omission, approximately 5% of the total cells Is Mitochondrial Uncoupling Essential to the Molecular expressed the neuronal marker microtubule-associated protein 2
Mechanisms of Many Natural Antiaging Therapies? (MAP2) after 7 days in vitro (DIV). This proportion increased to 60% after 15 DIV. To induce the DA phenotype, single cell dissociated hNSCs were plated in control media or in media containing 20 ng/ml C. Edwards,* V. Delic,* N. Copes,* O. Phillips,* T-A. Phan,* of bFGF and 75% (v/v) of glial conditioned media. After 24 h in S. Medrano,* K. Noble,* P. Bickford, † ‡ and P. Bradshaw* culture, 1% of the total cells expressed tyrosine hydroxylase (TH, marker for DA neurons), which represented approximately 30% of the *Department of Cell Biology, Microbiology, and Molecular Biology, total number of β-tubulin class III immunoreactive neurons. A time University of South Florida, Tampa, FL, USA course study demonstrated that the number of dopaminergic neurons †Center for Excellence in Aging and Brain Repair, Department of steadily increased to 3% of the total DAPI-positive cells after 7 DIV.
Neurosurgery and Brain Repair, University of South Florida Morsani This proportion of TH-ir cells represented approximately 76% of the College of Medicine, Tampa, FL, USA total neuronal population. To test the ability of this cell line to engraft ‡James A. Haley Veterans' Administration Medical Hospital, and differentiate into DA neurons, we transplanted them into the basal Tampa, FL, USA ganglia and substantia nigra (SN) of an MPTP-lesioned nonhuman pri-NT-020, a patented proprietary formulation of blueberries, green mate (NHP) model of PD. Two months after cell transplantation, the tea, carnosine, and vitamin D 3 available from Natura Therapeutics, grafted hNSCs differentiated into TH-expressing cells. These data Inc., has been shown to improve spatial memory performance, increase demonstrate for the first time that hNSCs incubated in the DA-inducprogenitor cell proliferation, and decrease inflammation in aged rats. ing conditions maintain the newly induced phenotype in vivo after 2
Here, we show that NT-020 can also extend the mean and maximal months. Further studies are necessary to identify the long-term funclife span of C. elegans nematode worms and increase their resistance tional integration and dopamine replacement in the denervated striatum.
against heat stress. C. elegans given NT-020 also had increased oxy- mice. Specifically we are determining the effects of NT-020 on oxy-Chronic neuropathic pain is caused by brain or spinal cord injury, nerve lesion, diabetic neuropathy, amputation, and neuromuscular dis-gen consumption, ATP levels, and ROS production in these cell lines to determine if the bioenergetic effects observed in C. elegans are orders. Neuropathic pain enhances sensitivity to touch and pain perception including phantom pain. So far there are no suitable treatments evolutionarily conserved and may play a role in the neuroprotective effects of NT-020 in mammals.
available. Thus, new treatment options to reduce these symptoms and to enhance pain management are needed. In animal models of chronic P.C.B. is a cofounder of Natura Therapeutics, Inc.
neuropathic pain, some of the clinical symptoms can be simulated by Human Umbilical Cord Blood Cells Reduce Behavioral Deficits constriction, ligation, or transection of sensory and/or motor spinal and Amyloid Levels in the PSAPP Alzheimer Mouse Model nerves. Rats develop neuropathic pain slowly and hypersensitivity could be seen up to 2-4 weeks after nerve injury. In a rat model of J. Ehrhart,* † ‡ D. Darlington,* C. D. Sanberg, ‡ N. Kuzmin-Nichols, ‡ L4 and L5 nerve ligation, our laboratory was the first to show that P. R. Sanberg, † and J. X. Tan* † breakdown of the blood-spinal cord barrier (BSCB) to albumin and activation of astrocytes over 2-10 weeks were most prominent on the * tion. In addition, the potential role of cerebrolysin, a mixture of several neurotrophic factors and active peptide fragments was also evaluated Pathological amyloidosis is a hallmark of Alzheimer's disease in this model. Spinal nerve ligation of L4 and L5 was performed and (AD), a dementia disorder affecting 20 million worldwide. Most currats were administered Cu, Ag, or Al nanoparticles (50-60 nm; 50 rent therapeutic strategies for the symptomatic and disease-modifying mg/kg, IP) once daily for 10 days. In these animals, albumin immunotreatment of AD have met with disappointment. Consequently, a more reactivity for BSCB dysfunction, glial fibrillary acidic protein (GFAP) effective treatment or prophylaxis is needed. Amyloidβ (Aβ) is a key reactivity for astrocytic activation, and Nissl staining for neural injurprotein in the regulation of AD. Postmortem and basic research studies were examined after 2, 4, 8, and 10 weeks after nerve ligation. ies, demonstrating glial cell activation in close proximity to amyloid Nanoparticle-treated rats exhibited prolonged hypersensitivity to exterplaques (a recognized inflammation marker), have confirmed that nal stimulation (fur touching) up to 8 weeks. Leakage of albumin and inflammatory processes play a role in the pathology of AD.
activation of astrocytes in the spinal cord segments T10, T12, and L5 Previously, we have shown that human umbilical cord blood cells were exacerbated by 120% at 4 weeks, 250% at 8 weeks, and 300% (hUCBCs, U-CORD-CELL TM ) provide cognitive recovery in animal at 10 weeks after ligation in the nanoparticle-treated group. This effect models of neurodegenerative disease through modulation of immune was most marked in Cu-and Ag-treated animals. Neuronal injury function. Moreover, we showed that multiple low-dose injections of closely corresponded to albumin leakage in the spinal cord. Cerebro-HUCBCs in AD mouse models caused a reduction in cerebral Aβ lysin in high doses (5 ml/kg) if coadministered with nanoparticles levels/β-amyloid deposits, which further resulted in increased serum daily was able to reduce morphological changes in the cord effeclevels of Aβ 42 . In this study, we continued investigation of the tively. However, cerebrolysin given after 4-6 days of nanoparticle safety and efficacy of hUCBCs in a double transgenic presenilin-amyadministration failed to induce sufficient neuroprotection. The drug loid precursor protein (PSAPP) mouse model of AD. Results demonalso reduced hyperalgesia if given as a pretreatment. These observastrate that hUCBCs are able to improve memory function and tions are the first to show that nanoparticles potentiate the duration of locomotor ability in these PSAPP mice. Furthermore, by using ELISA hyperalgesia of neuropathic pain and exacerbate disturbances in spinal and Western blotting techniques we were able to observe altered amycord microfluid environment. Cerebrolysin in high doses is able to loid precursor protein processing, a major hallmark in Alzheimer's thwart these changes indicating a potential role of the drug in pain disease. This resulted in reductions in both the Aβ-amyloidogenic pathmanagement. This research is very timely in neuropathic pain and the way and overall reductions in the Aβ peptide. Whereas data suggest that data are important for our increased understanding of these phenomena hUCBC infusion mitigates AD-like pathology, no optimal dosing and in order to find a good cure. safety data have been elucidated. As part of our safety characterization, the purpose of this study was to determine hUCBC presence and biodis-Adenovirus-Generated Induced Pluripotent Stem Cells Survive tribution in hUCBC-infused PSAPP mice 24 and 72 h postadministraand Differentiate Into Mature Neuronal Phenotypes Following tion. Longer term incubations of 7 and 30 days in Spraque-Dawley rats Transplantation Into a Healthy Rat Striatum were also performed to further reinforce our findings.
Saneron CCEL Therapeutics, Inc. is a biotechnological company K. D. Fink,* † ‡ A. T. Crane,* J. Rossignol,* § X. Lévêque, † ‡ that uses umbilical cord blood cells for the treatment of a number P. Starski,* R. Hearnes,* M. Lu,* § T. H. Nguyen, ¶ of disorders. J.X.T. is a consultant for and P.R.S. is cofounder of L. Lescaudron, † ‡ and G. L. Dunbar* § Saneron. C.D.S., N.K.-N., P.R.S., and J.X.T tumors following transplantation. In the last 10 years, the use of adult stem cells, such as bone marrow-derived mesenchymal stem cells Cluj-Napoca, Romania 778 ABSTRACTS (MSCs), has gained significant interest due to the fact that they are using identical experimental parameters as our previous work on STN DBS, we investigated whether DBS of the GPi halts ongoing SNc readily available, are subject to fewer ethical considerations, and have been shown to survive following transplantation into the brains of ani-degeneration induced by 6-OHDA. We conducted long-term GPi DBS in male rats that received unilateral, intrastriatal 6-OHDA. Two weeks mals that model various diseases. However, MSCs lack the ability to differentiate into neuronal lineages following transplantation. Cur-post-6-OHDA, rats with approximately 50% loss of SNc DA neurons were randomly assigned to receive active or inactive stimulation con-rently, the use of induced pluripotent stem cells (iPSCs) provides considerable promise as an alternative approach. The use of iPSCs tinuously for 2 weeks. During this 2-4-week post-6-OHDA interval, SNc degeneration typically progresses to 75% in lesioned, untreated circumvents ethical issues and they are more readily available, as they are derived from adult tissue, but the method of producing these cells rats. In contrast, STN DBS halts SNc degeneration at 50%. Forelimb use asymmetry measured via the cylinder task was used to prescreen usually involve pro-oncogenes, such as c-Myc and kruppel-like factor 4 (Klf4), which become permanently integrated into the genome dur-for lesion severity and functional efficacy of GPi DBS. Electrode placement in the GPi was verified postmortem via Kluver-Barerra his-ing reprogramming with retroviruses or lentiviruses. The use of a nonintegrating adenovirus for cell transfection avoids this problem.
tochemistry. Tyrosine hydroxylase-immunoreactive (TH-ir) neurons of the SNc were quantified using unbiased stereology. All rats exhibited However, the extent to which transplanted adenovirus-generated iPSCs can survive and differentiate into functional neurons, without forming an approximate 75% loss of THir SNc neurons 4 weeks postlesion regardless of treatment group; no difference between active and inac-tumors, is unknown and is the focus of the present study. In the first part of this study, we found that iPSCs could be derived from both rat tive groups receiving GPi DBS was observed. Our data reveal that long-term GPi DBS does not halt ongoing SNc degeneration induced bone marrow MSCs and tail-tip fibroblasts (TTF) using a single cassette lentivirus (LN) [octamer binding transcription factor 4 (Oct4), by 6-OHDA. These results are in sharp contrast to the neuroprotective effect of STN DBS under identical lesion and treatment time course sex determining region Y box 2 (Sox2), Klf4, and c-Myc] or a combination of adenoviruses (AD) (Oct4, Sox2, Klf4, and c-Myc). This was parameters. Despite equivalent symptomatic efficacy of STN and GPi DBS in PD patients, these data suggest that stimulation-associated confirmed using flow cytometry and immunocytochemistry for the pluripotent markers stage-specific embryonic antigen 3 (SSEA3), neuroprotection is specific to STN placement. Studies in our lab are continuing to investigate the mechanism of STN DBS-mediated neuro-SSEA4, Tra-1-60, Nanog, and Oct4. The iPSCs (MSC-AD, MSC-LN, TTF-AD, and TTF-LN) were analyzed in vitro for integration of the protection. Supported by the Morris K. Udall Center of Excellence for Parkin-reprogramming genes, neurotrophic factors, proliferation, and pro-and anti-inflammatory molecules using RT-PCR. Following in vitro analyson's Disease Research at Michigan State University NS058830 (T.J.C.). sis, 400,000 TTF-AD iPSCs were unilaterally transplanted into the right striatum of 20 healthy adult rats. Brains were analyzed for graft Analysis of Dopamine Neuron Subtypes in Ventral Mesencephalic Grafts in a Rat Model of Parkinson's Disease survival, inflammatory response, and neuronal or glial differentiation at 5, 21, 63, and 90 days posttransplantation. Graft survival was observed at all time points, although graft size decreased dramatically M. Fjodorova, E. Torres, S. Dunnett, and A. Rosser between 5 and 21 days and 21 and 63days posttransplantation, indicating either migration of the cells or graft rejection. Immature, develop-Brain Repair Group, School of Biosciences, Cardiff University, Cardiff, UK ing, and mature neuronal phenotypes were observed within the transplantation sites at 5, 21, 63, and 90 days posttransplantation, Embryonic ventral mesencephalic grafts contain two dopamine respectively. The observed survival, differentiation into mature neu-(DA) neuron subtypes: A9 neurons of the substantia nigra pars comronal phenotypes, and the absence of tumor formation suggests that pacta and A10 neurons of the ventral tegmental area. It has previously these adenovirus-created iPSCs may provide a safe and viable alternabeen reported that A9 and A10 cells can be identified on the basis of tive to ESCs and MSCs for therapeutic treatment of CNS disorders. their morphology, location within the graft, and protein expression. Support for this project was provided by a PUF grant (to K.D.F.) We have already characterized DA cell populations in embryonic age and funding from the John G. Kulhavi Professorship and Field Neuro-12-day-old (E12) and E14 grafts into the striatum in a unilateral rat sciences Institute (to G.L.D. et al., N. Engl. J. Med., 2011) . Whereas the GPi has been less comtex all receive midbrain dopamine innervations, whereas the hippomonly targeted for DBS than the STN, the same study suggests that campus receives none and will make a good control site. We also aim GPi DBS may provide better outcomes for patients with psychiatric to elaborate the overlap in Girk2 and calbindin staining in the graft, comorbidities. Beyond symptomatic efficacy, our laboratory and othand investigate the morphology of TH + /Girk2 + and TH + /calbindin + neuers have demonstrated that high-frequency DBS of the STN provides rons in the grafts to confirm that they represent two different subtypes neuroprotection for dopaminergic neurons of the substantia nigra pars of DA neurons. compacta (SNc) in the 6-hydroxydopamine (6-OHDA) rat model of PD (Spieles-Engemann et al., Neurobiol. Dis., 2010) . Clinical evidence also suggests that STN DBS may have disease-modifying effects in PD patients. However, whether GPi DBS has similar neuroprotective potential has not been investigated. In the present study,
Blood-Brain Barrier Impairment in MPS III Patients:
We recently reported the importance of timing of therapeutic intervention in experimental traumatic brain injury (TBI) (Glover et al., in Case Reports press), which may be characterized by genetic and histologic neuro-S. Garbuzova-Davis,* † ‡ S. Mitril,* S. Sallot,* vascular proteinase alterations (Borlongan and colleagues, 2009), and D. Hernandez-Ontiveros,* and P. R. Sanberg* ‡ § inflammation and apoptosis (Borlongan and colleagues, 2010) were significantly downregulated in the hemisphere contralateral to within cells and to eventual progressive cerebral and systemic organ the TBI-impacted hemisphere. The three cytokines, interleukin-5 (ILabnormalities. Different enzyme deficiencies in the HS degradation 5), IL-6, and macrophage inflammatory protein-3a (MIP-3a), were sigpathway comprise the four MPS III subcategories (A, B, C, D). Since nificantly suppressed in both ipsilateral and contralateral hemispheres neuropathological manifestations are common to all MPS III types, of TBI rats compared to the control rats. The remaining five cytokines determining blood-brain barrier (BBB) condition may be critical to did not significantly differ between TBI and control rats, indicating an understand potential additional mechanisms of this devastating disoroverwhelming downregulation of the entire panel of cytokines anader. Garbuzova-Davis et al. (2011) showed BBB structural and funclyzed here. Note that a parallel study processing plasma, instead of tional impairment of various brain structures in a MPS III B mouse brain tissues, for the present cohort of animals revealed neither upregmodel. Endothelial and pericyte cell damage and astrocyte degeneraulation nor downregulation of any of these same cytokines between tion compromise the BBB even at the early disease stage, resulting in TBI and controls. Contrary to the early inflammatory response markers vascular leakage. Edematous spaces around microvessels and highly seen in adult TBI, the present neonatal TBI study demonstrated the vacuolated perivascular macrophages have been noted. Accumulation reversed cytokine profile of downregulation, suggesting a robust of GM3 ganglioside, a secondary storage product, was determined in endogenous anti-inflammatory response being mounted surprisingly endothelium microvasculature of multiple brain structures. These from a brain area remote from the site of injury (i.e., the contralateral results indicate severe BBB breakdown, which might accelerate neuhemisphere). This regenerative process may be unique to the highly ronal damage. However, little is known about the BBB competence in plastic neonatal brain, which is shown here as equally capable of cyto-MPS III patients. The aim of this study was to determine structural kine regulation following TBI. and functional integrity of the BBB in various brain structures of post- Fleming,* ¶ (occludin and claudin-5) was performed in serial brain sections. Immuand C. E. Sortwell ‡ nohistochemical staining for lysosomal accumulation within endothelial cells was also performed. Major findings of our study were: 1) *Department of Neurology, University of Cincinnati, capillary ultrastructure revealed endothelial and pericyte cell damage;
Cincinnati, OH, USA 2) lysosomal zebra bodies were indicated in a majority of endothelial †Graduate Program in Neuroscience, University of Cincinnati, cells and pericytes, rupturing cell membranes; 3) severe edematous Cincinnati, OH, USA space was noted around microvessels; 4) IgG microvascular leakage ‡Department of Translational Science and Molecular Medicine, was clearly indicated in multiple brain structures; 5) reductions of Michigan State University Grand Rapids, MI, USA occludin and claudin-5 were noted with variations between MPS III §Department of Neuroscience, University of Florida, types; 6) extensive lysosomal accumulation was determined in brain Gainesville, FL, USA microvasculature endothelium. These new findings of BBB structural ¶Department of Psychology, University of Cincinnati, and functional impairment, although from only two cases, MPS III A Cincinnati, OH, USA and MPS III D, may have implications for disease pathogenesis and should be considered in treatment development for MPS III. Special
Aging is the single most important risk factor for Parkinson's disattention should be given to endothelial cell function in view of possiease (PD). Mutations in the gene encoding α-synuclein (α-syn) have ble deterioration of influx and efflux transport systems needed to been linked to familial PD and viral vector-mediated α-syn overexmaintain proper CNS homeostasis. pression in the rodent nigrostriatal dopamine (DA) system recapitu-
Supported by the Children's Medical Research Foundation.
lates key pathological features of PD. To date, nigrostriatal pathology has been examined in young adult animal models overexpressing α-
Suppressed Cytokine Expression in Brains of Neonatal Rats
syn but has not been examined in the aged brain. The aged nigrostria-Immediately Following Traumatic Brain Injury Suggests tal system may have increased susceptibility to α-syn-mediated neuroa Robust Endogenous Anti-inflammatory Process toxicity due to enhanced nigral oxidative stress and neuroinflammation, both linked to α-syn mechanisms of neurotoxicity. To determine L. E. Glover, N. Tajiri, J. Ehrhart, J. Tan, Y. Kaneko, whether α-syn-mediated pathology is amplified with aging, we first and C. V. Borlongan intentionally developed a model with limited nigrostriatal degeneration in young adult rats. Recombinant adeno-associated virus serotype 2/5 Center of Excellence for Aging and Brain Repair, Department of Neurosurgery and Brain Repair, University of South Florida expressing human wild-type α-syn mixed 1:1 with rAAV2/5 expressing green fluorescent protein (GFP) or rAAV2/5-GFP alone was Morsani College of Medicine, Tampa, FL, USA injected intranigrally in rats 3 months of age. Every 4 weeks rats were Efficacy of Intrahippocampal Grafting of Subventricular Zone-Derived Neural Stem Cells for Easing Status tested for motor deficits using the cylinder test, bracing test, bilateral tactile stimulation test, and amphetamine-induced rotational asymme-Epilepticus-Induced Temporal Lobe Epilepsy and Related Comorbidities try. Young rats were sacrificed at 2 and 3 months post-vector injection and were analyzed for α-syn and GFP immunolabeling, stereology for surviving nigral tyrosine hydroxylase-ir neurons, and levels of striatal B. Hattiangady,* † ‡ R. Kuruba, ‡ B. Shuai,* † ‡ B. Waldau, ‡ DA and DA metabolites. Modest reductions in striatal DA (ϳ30%) and A. K. Shetty* † ‡ and surviving nigral DA neurons (ϳ20%) were observed in young rats. No differences were detected between groups in behavioral per-*Institute for Regenerative Medicine, Texas A&M Health Science formance, except that α-syn/GFP injected animals displayed deficits Center College of Medicine at Scott & White, Temple, TX, USA in the bracing task at 1 and 2 months. To make direct comparisons in †Research Service, Veterans Affairs Medical Centers of Durham, NC aged rats, 20-month-old rats were injected with identical vectors, anaand Temple, TX, USA lyzed for motor impairments, and sacrificed 3 months post-vector ‡Division of Neurosurgery, Duke University Medical Center, injection. Analysis of toxicity in aged rats is ongoing with the addition Durham, NC, USA of α-syn-ir nigral neuron and striatal aggregate quantification. Results
Status epilepticus (SE) is an emergency condition typified by prowill determine if the aged nigrostriatal system is more susceptible to longed seizure activity, which affects over 150,000 Americans every α-syn-mediated neurotoxicity. If so, α-syn overexpression in the aged
year. Despite the antiepileptic drug therapy after SE, a sizeable fracrat may be an improved model for development of novel PD therapies tion of SE survivors develop temporal lobe epilepsy (TLE), typified and delineating the cause(s) of increased susceptibility may provide by recurrent complex partial seizures and impairments in memory and insight into the disease process itself. mood function. Currently, there is no efficient therapy for easing both Supported by NS058682 (C.E.S.) and the Morris K. Udall Center of complex partial seizures and memory and mood dysfunction in TLE.
Excellence for Parkinson's Disease Research at MSU NS058830 (T.J.C.).
In this context, neural stem cell (NSC) grafting approach has received great interest because of the ability of NSC grafts for mediating func-Forelimb Neuroplasticity Following Incomplete Cervical Spinal tional recovery in other prototypes of brain injury. We examined the week; 32 h/month). At 6 months post-SE, rats in all groups were model of high cSCI, lateral C2 spinal cord hemisection (C2Hx), the examined for recognition memory function using a novel object recogpresent work examines the muscular and neuroanatomical substrates nition test and depressive-like behavior using a forced swim test. At 8 underlying upper extremity dysfunction and recovery following months post-SE, rats from grafted SE and SE-alone groups were incomplete cSCI. Gross forelimb motor function was assessed prior implanted with epidural electrodes and electroencephalographic (EEG) to, and at 1 and 8 weeks postinjury using the limb-use asymmetry activity was recorded continuously for 5 days (ϳ120 h) using a video-(cylinder) test. Immunohistochemical techniques were used to assess EEG system (AS40; Grass Telefactor). In comparison to rats belongforelimb muscle fiber cross-sectional area (CSA). The neuroanatomiing to sham-grafted SE and SE-alone groups, rats in the grafted SE cal circuitry of the forelimb was assessed using retrograde transneugroup exhibited greatly reduced SRS (78-82% reduction in all SRS; ronal tracing techniques. Initial results indicate dramatic reductions in 72-82% reduction in stage-V SRS; 30% reduction in the duration of ipsilateral forelimb use (p < 0.01) and muscle fiber CSA (p < 0.05) at individual SRS; and 65% reduction in SRS activity time for the 1 week post-C2Hx. By 8 weeks postinjury, improvements in ipsilateral recording period). Analyses with EEG also revealed much reduced forelimb use (p < 0.01) and increased muscle fiber CSA (p < 0.05) frequency and intensity of SRS in the grafted SE group, in comparison were observed. Taken together, these initial results indicate substantial to the SE-alone group. Grafted SE rats also displayed much improved muscular remodeling and modest recovery of forelimb function folrecognition memory and mood function than SE-alone rats (p < 0.01). lowing cSCI. Preliminary results from tracing studies reveal the loca-Histological analyses revealed a yield of graft-derived cells that was tion and distribution of forelimb motoneurons and interneurons in the equivalent to ϳ110% of injected cells, and pervasive migration of cervical spinal cord and associated neurons within the brain stem and graft-derived cells into dentate granule cell layer as well as other motor cortex of uninjured animals. Ongoing studies are exploring the regions of the hippocampus. Phenotypic analyses revealed differentianeuroanatomical circuitry associated with forelimb dysfunction and tion of ϳ25% of graft-derived cells into GABAergic interneurons and recovery after injury. These experiments are the first to examine the other graft-derived cells into different types of glia. Thus, intrahippocombined muscular and neuroanatomical mechanisms underlying neucampal grafting of SVZ-derived NSCs early after SE is highly efficaroplasticity and recovery of upper extremity function following cSCI cious for easing both SRS and other comorbidities of TLE. and may aid in identifying potential therapeutic targets for rehabilitation interventions. Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by motor neuron degeneration in the brain and spinal cord resulting in progressive muscle weakness, paralysis, and death.
Blood-Brain/Spinal Cord Barrier Alterations in ALS Patients
injured versus control sides of the spinal cord (p < 0.01), validating the efficacy of our model to produce a demyelinated niche. No significant Blood-brain barrier (BBB) and blood-spinal cord barrier (BSCB) impairment have been suggested as important factors involving ALS differences were found between white matter sparing in vehicle-treated aged versus young animals. In parallel, no significant differences in pathogenesis. In the G93A superoxide dismutase 1 (SOD1) rodent model of ALS, structural and functional alterations of the BBB/BSCB either ladderbeam or CatWalk of young versus aged mice were detected, suggesting that age did not affect demyelination or spontane-have been detected in the presymptomatic disease stage, worsening with disease progression. We hypothesized alterations to the microvas-ous recovery. CatWalk analysis revealed improved stepping pattern (p = 0.05) and higher maximum contact area in aged animals receiving cular integrity of the BBB/BSCB in ALS patients. Capillaries in gray and white matter of the medulla, cervical, and lumbar spinal cord post-hCNS-SCns in comparison to vehicle (p = 0.05) and horizontal ladderbeam data showed a significant reduction in the number of forelimb mortem tissues, obtained from tissue banks, from 25 sporadic ALS patients and 18 age-matched control subjects were analyzed for struc-errors made by cell-treated aged animals compared to vehicle (p < 0.05). No evidence of allodynia/altered hindlimb sensitivity was tural (electron microscopy) and functional integrity (immunohistochemistry). Tight junction protein expressions were also evaluated observed in any of the groups. Histological data demonstrated the presence of 82,519 hCNS-SCns in aged mice 12 weeks posttransplant, (Western blot). Ultrastructural analysis of capillaries in ALS tissues confirmed endothelial and pericyte cell damage, intra-and extracellu-1.1 times more than the number of cells originally transplanted, suggesting robust survival. As well, only 5.5% of cells were found at lar edema, and a large perivascular accumulation of collagen. Western blot analysis revealed downregulation of tight junction proteins in both the injury epicenter, suggesting long-distance migration to areas where hCNS-SCns could mediate repair. Further, only 7.8% of engrafted gray and white matter capillaries in all examined ALS tissues. IgG vascular leakage was detected by immunohistochemistry, indicating cells expressed astrocytic markers while 72% of hCNS-SCns expressed Olig-2, suggesting predominant oligodendrocytic differenti-BBB/BSCB disruption. Staining for CD31 (PECAM-1) and CD105 (endoglin) revealed ill-defined vessel margins and discontinuities in ation. Collectively, these results suggest that the aging injured niche supports oligodendroglial cell fate and may mediate axonal repair. The the endothelial lining accompanied by asymmetrical increases in the capillary wall extensions. These results demonstrate microvascular data extend our previous findings in thoracic SCI, now demonstrating cell-mediated recovery of motor function following cervical SCI in alterations in ALS leading to substantial BBB/BSCB impairment.
Supported by the Muscular Dystrophy Association (Grant #92452). aged animals, and suggest the capacity of hCNS-SCns to improve motor function and promote oligodendroglial differentiation in animals Human Neural Stem Cells Survive, Differentiate, and Promote at multiple ages and SCI types. neous recovery and anatomical plasticity, less is known about respira-#Stem Cells Inc., Newark, CA, USA tory plasticity following more clinically relevant contusion injuries at **Physical Medicine and Rehabilitation, University of California, the level of the phrenic nucleus (C3-C5/6). The goal of the present Irvine, CA, USA study was to define the extent of phrenic motoneuron (PhMN) com- † †Anatomy and Neurobiology, University of California, promise following lateral midcervical contusions and concomitant Irvine, CA, USA temporal changes in diaphragm electromyogram (diaEMG) activity and ventilatory function. Telemetric electrodes were bilaterally The average age of the clinical population of spinal cord injury (SCI) is 34 years old. Yet biological mechanisms of recovery/repair in implanted in the diaphragms of adult female rats. One week later, all animals received a C3/4 contusion (Infinite Horizon, 150 kDa present most animal models are generally addressed in young rodents between 8 and 12 weeks. Further, while the thoracic contusion paradigm is the force). DiaEMG recordings were made simultaneously with ventilatory assessment (using whole-body plethysmography) in awake experimental model of choice for SCI, the clinical incidence of cervical SCI is greater than thoracic and is frequently accompanied by ver-unanesthetized animals. Measurements were made preinjury, daily during the first week postinjury, and weekly thereafter while animals tebral compression. Notably, oligodendrocytes are particularly vulnerable to ischemia/compression injuries, and chemical demyelination models were breathing room or hypercapnic (7% CO 2 ) air (using whole-body plethysmography). Initial results demonstrate the feasibility of long-demonstrate an age-related failure of remyelination by endogenous oligoprogenitors. Additionally, unilateral injuries, in particular, result in term telemetric recordings of diaEMG activity. Within the first two postinjury days, diaphragm activity increases while ventilation is rela-predominant loss of function on the ipsilateral side but may also alter the contralateral niche. In the present study we: 1) characterize pathol-tively unaffected. Furthermore, diaphragm activity and overall ventilatory responses to respiratory challenge (hypercapnia) are dramatically ogy in young versus aged animals in a newly developed unilateral cervical injury model that combines contusion and compression of the attenuated compared with that seen preinjury. By 1 week postinjury, the ventilatory response to challenge normalizes. Although there is spinal cord; and 2) test the capacity of human neural stem cells (hCNS-SCns) to promote recovery/repair in this model. Immunodefi-some recovery of diaEMG responses to challenge, the extent remains significantly reduced relative to what occurs preinjury. This deficit cient mice (young: 3-4 months old; aged: 16-17 months old) received 30 kDa unilateral contusion injuries with a 5-s compression on the remains persistent at 4 weeks postinjury. Persistent diaphragm dysfunction in the presence of otherwise normal ventilatory patterns sug-same side as the contusion at the C5 vertebral level. Nine days postinjury, aged mice received either hCNS-SCns or vehicle while young gests significant compensation in other spinal respiratory motor regions (e.g., intercostal circuitry). Ongoing studies are quantifying animals only received vehicle. Following terminal behavioral analyses, tissue was collected for histology. Immunostaining using myelin basic PhMN primary and secondary loss and examining the relationship between motoneuron loss and diaphragm dysfunction. protein revealed significantly reduced white matter sparing on the 782 ABSTRACTS
Recovery of Function in a Mouse Unilateral Cervical Spinal

Supported by NIH RO1 NS054025, the Anne and Oscar Lackner
TFF1 is expressed in the ventral mesencephalon of the developing and adult rat brain. This finding is of special interest in relation to Parkin-Chair in Medicine, and University of Florida Research Opportunity Funds.
son's disease, a neurodegenerative disease mainly characterized by a progressive loss of dopaminergic neurons in the substantia nigra (SN) Assessing the Safety of Human Cerebral Endothelial Cell of the ventral mesencephalon. In the present study, we investigated the Transplantation in Stroke Animals With Emphasis on the expression pattern of TFF1 in adult 6-hydroxydopamine (6-OHDA)-Mechanism of Action lesioned hemiparkinsonian rats versus unlesioned controls. In the unlesioned ventral mesencephalon, TFF1-immunoreactive (-ir) cells were H. Ishikawa,* K. Sinozuka,* N. Tajiri,* L. E. Glover,* predominantly detected in the SN pars compacta (SNc) and the ventral J. Vasconcellos,* A. Mayo-Perez,* C. Metcalf,* Y. Kaneko,* tegmental area. While we found that around 90% of the TFF1-ir cells S. U. Kim, † and C. V. Borlongan* in the SNc coexpressed tyrosine hydroxylase (TH), only a subpopulation of TH-ir neurons also expressed TFF1. We observed that some *Center of Excellence for Aging and Brain Repair, Department TFF1-ir cells in the SNc coexpressed the calcium-binding proteins calof Neurosurgery and Brain Repair, University of South Florida bindin or calretinin and NeuN, suggestive of a neuronal phenotype, Morsani College of Medicine, Tampa, FL, USA which was supported by a lack of colocalization with the astroglial †Department of Neurology, University British Columbia, marker glial fibrillary acidic protein. Intrastriatal injection of the retro-Vancouver, BC, Canada grade tracer Fluorogold resulted in labeling of a number of TFF1-Stem cell therapy has emerged as an experimental treatment for expressing cells in the SNc, showing that a significant fraction of the stroke. Despite the reported functional recovery in transplanted stroke TFF1-ir cells were projection neurons. This was also reflected by unianimals and limited clinical trials in stroke patients, a major gap in lateral loss of TFF1-ir cells in the SNc of 6-OHDA-lesioned rats. In our knowledge is the mechanism of action underlying cell therapy.
unlesioned rats only a few small TFF1-ir cells were scattered over the We examine the fate differentiation of transplanted human cerebral striatum, but their numbers were significantly increased after 6-OHDA endothelial cells (HEN6s) in a stroke animal model, using markers of lesion. At present it remains unclear whether TFF1 expression was neurogenesis and vasculogenesis as outcome parameters, combined upregulated in already existing cells or whether the lesion had induced with stress and sensorimotor tests using the Rat Grimace Scale (RGS) neurogenesis of TFF1-ir cells. In conclusion, our findings demonstrate and modified Neurogical Severity Score (mNSS). Ten-week-old rats that distinct subpopulations of rodent midbrain dopaminergic neurons underwent a 1-h middle cerebral artery occlusion. Animals were ranexpress TFF1 and that this expression pattern is altered in a rat model domly assigned to receive stereotaxic transplantation of vehicle, 1, 2, of Parkinson's disease. or 4 million HEN6s 3e h after occlusion. Rats were sacrificed 7 days postreperfusion for immunohistochemistry using antibodies against Attenuation of Spinal Cord Injury-Induced Pain in Rats neuronal, vascular, and specific human transplanted cell markers.
by Cell-Based and Gene Therapy 2,3,5-Triphenyltetrazolium chloride staining was conducted in alternate sections to reveal infarct volume. All animals were videotaped S. Jergova, D. Collante, N. Pathak, S. Jani, S. Gajavelli, for 15 min at day 1, 3, and 7 for the RGS stress test. After recording, and J. Sagen subjects' sensorimotor function was assessed by mNSS. Increased expression of host neuronal and vascular markers was detected in the University of Miami, Miller School of Medicine, Miami Project, stroke core, and closely adjacent to the transplanted cells. Some trans-Miami, FL, USA planted cells differentiated into a microvascular phenotype and jux-Neuropathic pain following spinal cord injury (SCI) insufficiently taposed to the host vasculature. Neurogenic and vasculogenic responds to current pharmacological treatment. Therefore, it is necesupregulation was more pronounced in animals that received the 4 milsary to identify new therapeutic targets and approaches. Hypothesized lion cell dose, but the other doses also exhibited both regenerative mechanisms underlying chronic neuropathic pain following injury to processes. Infarct volume in transplanted stroke animals was signifithe nervous system include increased hyperexcitability of spinal dorsal cantly lower than vehicle-infused stroke animals. The mNSS revealed horn neurons due to loss or dysfunction of inhibitory γ-aminobutyric significant improvement of sensorimotor functions in 4 million HEN6s acid (GABA)-ergic interneurons, and enhanced excitatory glutamate in comparison with saline group (p < 0.05). Interestingly, RGS signaling through NMDA receptors. Targeting GABAergic and glutarevealed higher stress score in 4 million HEN6s than the other groups matergic signaling at the same time may enhance pain relief. Our pre-(p < 0.05). We found a correlation between vasculogenesis and neurovious research showed that intraspinal transplantation of recombinant genesis following transplantation of HEN6s, suggesting a dual pronged GABAergic progenitors releasing NMDA receptor antagonist serine regenerative process in stroke animals, which correlated with histogranin (SHG) attenuates hyperalgesia after SCI. The current improved sensorimotor functions. The increased stress behavior in experiment aims to increase the amount of released SHG using plastransplanted stroke animals may be related to host immune response mids with multiple copies of the SHG gene to enhance the analgesic to the human xenograft. A better understanding of regenerative proeffect of grafted recombinant cells for SCI induced pain. GABAergic cesses, as well as potential side effects, will allow a critical assessment neuronal precursor cells (NPCs) were harvested from E14 rat embryos of the risk-to-benefit ratio of cell therapy in stroke. and transduced by lentivirus encoding six copies of SHG cDNA. Spinal cord clip compression was used to induce central neuropathic pain.
Expression of Trefoil Factor 1 in the Nigrostriatal System
One week after intraspinal injection of engineered cells, attenuation of of Hemiparkinsonian Rats Versus Unlesioned Controls tactile allodynia was observed in SCI animals, with further improvement in the following weeks. Over 50% reduction in cold allodynia P. Jensen,* † M. Heimberg, † A. D. Ducray, † H. R. Widmer, † was observed 2 weeks postgrafting. The analgesic effect of grafting and M. Meyer* persisted for 6 weeks and was reduced by intrathecal injection of SHG antibody. In order to further enhance antinociceptive effect, we were *Department of Neurobiology Research, Institute of Molecular looking for potential candidates acting synergistically with SHG. It Medicine, University of Southern Denmark, Odense C, Denmark has been shown that SHG enhances the effect of opioid treatment and †Department of Neurosurgery, University of Berne, Inselspital, thus reduces aversive side effects of high-dose opioid use. Endomor-Berne, Switzerland phins (EMs), endogenous opioid peptides with high selectivity for µopioid receptors, are therefore suitable for gene therapy in combination Trefoil factor 1 (TFF1) belongs to a family of soluble peptides with a characteristic tree-looped trefoil structure. TFFs are particularly with SHG. To test the efficiency of such combined therapy, an intraspinal injection of a viral construct encoding EM1 and an intrathecal expressed in the gastrointestinal tract, where they play critical roles in the function and structural composition of the mucosal barrier. More injection of SHG were evaluated in SCI animals. Lenti-EM1 was intraspinally injected 2 weeks post-SCI injury. Attenuation of tactile recently, TFF1 has been suggested to function as a neuropeptide, but only limited information is available on its expression and functional and cold allodynia was observed 2 weeks post-lenti-EM1 injection and persisted for several weeks. Intrathecal injection of SHG further significance in the CNS. Our preliminary studies have revealed that reduced SCI-induced hypersensitivity to cold and tactile stimuli. There is an increasing body of evidence suggesting that patients typically present with unilateral motor symptoms such as resting tremor, which progresses bilaterally over time with increasing peripheral factors may contribute to the central degenerative process. Symptomatically, gastrointestinal (GI) impairment is present in severity. Motor symptoms arise from the progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc), approximately 80% of PD patients who suffer from constipation years to decades before the onset of movement disorders. Pathologically, resulting in the loss of dopaminergic innervation in the terminal fields of the caudate/putamen. Although a majority of PD cases are sporadic, while LBs distribute throughout the central nervous system (CNS) from the lower brain stem to the cerebral cortex, α-syn aggregates and several familial forms of PD have been identified. α-Synuclein (αsyn) was the first such gene to be identified. Alterations in the coding LBs have also been identified in the enteric nervous system (ENS) of PD patients and appear to be present prior to clinical PD symptom sequence and expression levels of the α-syn gene (SNCA) are causative in, or confer enhanced risk for, developing PD and several other onset. Anatomically, the intestinal ENS is extensively innervated from the duodenum to the transverse colon by vagal nerves that originate neurodegenerative disorders. Although the exact mechanisms whereby α-syn impacts disease pathogenesis are poorly understood, the prevail-in the brain stem. These observations present the intriguing possibility that α-syn may accumulate in the GI tract and be transported to the ing hypothesis states that aggregated forms of α-syn are directly toxic to the cell. However, we previously showed that significant loss of αbrain stem where its aggregation can initiate neuronal degeneration.
Even if transport to the brain is not the initiating event in PD, the syn in postdevelopmental dopamine neurons leads to neurodegeneration, suggesting that maintaining some level of functional α-syn is presence of α-syn aggregation in the GI tract presymptom development may provide the means to develop a simple biomarker to identify required for dopamine neuron survival. In contrast to the prevailing hypothesis, we propose that α-syn aggregation leads to the reduced patients presymptomatically so that therapeutics can be designed to prevent the onset of parkinsonian symptoms. Unfortunately, little is bioavailability of monomeric, functional α-syn, thus leading to neurotoxicity through a loss-of function (LOF) mechanism. To study this known regarding how these LBs form, when they form, or if α-syn is transported into the brain or vice versa. We hypothesize that systemi-hypothesis we utilized a form of α-syn that cannot form aggregates, yet retains its function. Previously, we demonstrated that intramolecu-cally administered lipopolysaccharide (LPS) and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) will compromise GI permeability lar cysteine interactions stabilize a particular conformation of α-syn, preventing oligomerization and aggregation in vitro. Here, we utilized and promote α-syn overexpression in neurons of the submucosal and myenteric plexuses of the GI system that then spread via vagal net-recombinant adeno-associated virus type 2/5 (rAAV2/5) to unilaterally deliver a mutant form of a nonaggregatable α-syn (with enhanced cys-works to the medulla where it can initiate neuropathology. To support this hypothesis, preliminary studies from our laboratory revealed that teine interactions) to the rat substantia nigra (SN). These vector injections were performed in both naive rats and rats receiving SN systemically administered LPS (a common bacterial endotoxin) and MPP + (a dopamine neurotoxin) causes increased α-syn accumulation injections of rAAV2/5 human wild-type α-syn, a rodent model of α-syn aggregation that exhibits neurodegeneration. In contrast to over-in the descending colons of mice in addition to significant SNpc neuron loss (Kelly et al.; poster presentation, ASNTR, 2011). Additional expression of wild-type human α-syn, overexpression of the nonaggregatable form of α-syn did not cause significant loss of neurons in findings from our laboratory revealed similar descending colonic αsyn accumulation in MPTP-lesioned and aged nonhuman primates the SN. Furthermore, coexpression of nonaggregatable α-syn together with wild-type α-syn prevented nigrostriatal denervation, indicating compared to young primates (Kordower et al.; poster presentation, SFN, 2011) . Recently published work from our lab in conjunction with that this species of α-syn provides neuroprotection. Quantification of tyrosine hydroxylase-positive (TH + , a dopamine neuron marker) neu-others demonstrated that increased intestinal permeability correlates with sigmoid mucosa α-syn staining and endotoxin exposure markers rites in the striatum and TH + neurons in the SN is under way. Our results suggest that, at least in part, neurotoxicity due to α-syn over-in early PD (Forsyth et al., 2011) . We propose to advance these studies by characterizing intestinal permeability and α-syn accumulation in expression is due to an aggregation-dependent LOF toxicity, which can be rescued by supplementing a form of α-syn that cannot form vagal and nonvagal inputs throughout the ENS and CNS in a novel systemic LPS/MPTP model of PD. Effectively modeling the patho-aggregates. Moreover, these findings are in support of our novel hypothesis that α-syn-mediated disease is the result of loss of available genic process leading to SNpc cell death in PD is fundamental for developing preventative or disease-modifying therapies. These results functional α-syn.
are expected to have a positive impact because they will contribute to the use of routine colonic biopsies as potential tools for premortem neuropathological diagnoses of PD, as well as contribute to the relatively understudied peripheral pathology of PD.
ABSTRACTS
Long-Term Functional and Morphological Neuroprotection
hypoxia was mimicked by exposure to CoCl 2 . The rhSTC-1 also reduced cell death in primary cultures of rat cortical neurons exposed via Deep Brain Stimulation of the Subthalamic Nucleus in Rats to both CoCl 2 and interleukin-1β (IL-1β). In addition, the rhSTC-1 C. J. Kemp,* S. E. Gombash, † S. L. Wohlgenant,* reduced upregulation of IL-1β and induced nitric oxide synthase F. P. Manfredsson,* D. L. Fischer, ‡ B. F. Daley,* (iNOS) in microglia (BV2) exposed to oxygen and glucose depriva-K. Steece-Collier,* T. J. Collier,* and C. E. Sortwell* tion. The results supported previous indications that upregulation of STC-1 largely explains the protective effects of ischemia precondition-*Department of Translational Science & Molecular Medicine, ing in the brain. †Medical Research Institute, Chung-Ang University College however, the duration of this neuroprotection is unclear. In the present of Medicine, Seoul, Korea study we investigated the effects of STN DBS in the 6-hydroxydopamine (6-OHDA) rat model of PD during, immediately following, and
Cell replacement therapy and gene transfer to the diseased or long after the cessation of stimulation. Rats were unilaterally lesioned injured brain have provided the basis for the development of potenwith intrastriatal 6-OHDA, and electrodes were implanted in the ipsitially powerful new therapeutic strategies for a broad spectrum of lateral STN. Two weeks postlesion, rats were randomly assigned to human neurological diseases. However, the paucity of suitable cell receive either continuous STN stimulation lasting 2 weeks (active, types for cell replacement therapy in patients suffering from neurologin = 5) or not (inactive, n = 4) for 2 weeks' duration. The effect of cal disorders has hampered the development of this promising thera-STN DBS on contralateral forepaw use was assessed (cylinder task):
peutic approach. In recent years, neurons and glia have successfully at baseline; 2 weeks following 6-OHDA insult' and on completion of been generated from stem cells such as embryonic stem cells (ESCs), 2 weeks of continuous STN DBS, both during stimulation and immeinduced pluripotent stem cells (iPSCs), mesenchymal stem cells diately after cessation. Cylinder task was repeated at 5 and 24 h posts-(MSCs), and neural stem cells (NSCs), and extensive efforts by investimulation and at monthly intervals for 4 months. At the conclusion of tigators to develop stem cell-based brain transplantation therapies have the study neuroprotection of the nigrostriatal system was evaluated been carried out. We have previously generated continuously dividing via quantification of the tyrosine hydroxylase immunoreactive (TH-ir) immortalized cell lines of NSCs by introduction of oncogenes and neurons in the SNc and optical density of TH-ir neurites in the striaused these immortalized NSC lines in cell and gene therapy studies in tum. Active rats demonstrated complete amelioration of 6-OHDAanimal models of Parkinson's disease (PD), Huntington's disease induced deficits in contralateral forepaw use during stimulation that (HD), amyotrophic lateral sclerosis (ALS), Alzheimer's disease (AD), continued for 24 h following cessation of stimulation. Further, for the stroke, and brain tumors. Recently the FDA approved the City of Hope duration of the 4-month study, active rats used their contralateral fore-Medical Center in California to proceed with the first human NSC paw with greater frequency than inactive rats. Active rats exhibited an clinical trial to treat brain tumor and seven patients are receiving this attenuated TH-ir neuron cell loss in the SNc. Conversely, inactive rats suicide gene therapy. This human NSC line was produced in my labodisplayed continuing nigral TH-ir neuron degeneration. No differences ratory in UBC and the study is the first to use human NSC line to in striatal TH-ir neurite density were observed between treatment deliver an anticancer therapeutic agent. groups. In conclusion, neuroprotection of DA neurons in the SNc and functional improvements that follow a 2-week interval of STN DBS Methamphetamine-Induced Cerebral Vasculature Changes and are long lived, persisting for 4 months after the stimulation period has its Implications as a Risk for Parkinson's Disease Development ended. Further, the full magnitude of STN DBS-mediated improvements in forepaw akinesia can persist for as long as 24 h after the S. M. Kousik,* † S. M. Graves,* † T. C. Napier,* † cessation of stimulation. Lastly, our finding that STN DBS provides and P. M. Carvey* † ‡ neuroprotection for SNc DA neurons, but not striatal TH-ir neurites, suggests that long-term improvements in forepaw akinesia during and patients. Potential mechanisms of meth neurotoxicity include DA-quinone and reactive oxygen species-aided neuroinflammation, blood-Ischemia preconditioning of brain and other tissues increases the levels of stanniocalcin-1 (STC-1), a multifunctional hormone that was brain barrier (BBB) dysfunction, and hyperthermia. Clinical studies also report reduced regional cerebral blood flow (rCBF) in the puta-recently shown to reduce reactive oxygen species (ROS) by increasing expression of mitochondrial uncoupling protein 2. We recently pre-men and cortex of detoxified meth abusers. Our study focused on how meth-induced changes in the BBB, tissue perfusion, and the DA sys-pared recombinant human STC-1 in an E. coli system that provides large yields of the protein at low cost. The rhSTC-1 was biologically tem contribute to the vulnerability of meth abusers to PD. We hypothesized that acute and chronic meth treatment would result in BBB active as demonstrated by inhibition of apoptosis of mouse macrophages (RAW 264.7) exposed to either lipopolysaccharide (LPS) or dysfunction, tissue hypoperfusion in brain regions similar to those reported clinically, and nigrostriatal DA damage. Rats were treated hydrogen peroxide (H 2 O 2 ). In tests of neural cells, the rhSTC-1 reduced NF-κB signaling in a line of rat neuronal cells (B35) in which with acute saline, 3 or 9 mg/kg meth, or trained to self-administer meth chronically (ϳ2.2 mg/kg/day for 14 days), then perfused with interneurons in surrounding gray matter and 2) medullary neurons in the ventral respiratory column, raphe, and reticular nuclei. These fluorescein isothiocyanate-labeled albumin (FITC-LA), a vascular integrity marker. Additional rats treated with acute 9 mg/kg meth also results provide evidence for graft-mediated enhancement of post-C2Hx diaEMG activity that may involve a host-graft interneuronal relay. were perfused with Microfil-MV for microcomputed tomography (µCT). Rats given acute 3 or 9 mg/kg meth displayed FITC-LA leak- .964] in rats trained to self-administer meth, suggesting that chronic Health Professions, University of Florida, Gainesville, FL, USA meth may render this system more vulnerable to PD. Our findings concur with clinical reports of selective reduced rCBF in the sensori-Respiratory rhythm originates in ventral respiratory column (VRC) motor striatal regions. Reduced rCBF and hypoxia may destroy striatal neurons in the medulla, which extend axonal projections to spinal neu-DA terminals leading to DA cell damage in the nigra, thus contributing rons controlling inspiratory and expiratory muscle activity. Interrupto meth abuse as a risk factor for PD. This is the first preclinical study tion of those bulbospinal pathways results in altered patterns of on meth-induced cerebral vascular changes as a new mechanism of ventilation. While various neuroplastic changes have been shown in neurotoxicity and may provide a novel model for meth-induced PD spinal respiratory centers following cervical spinal cord injury (SCI), risk. Our results also suggest that striatal hypoxia may contribute to it is unknown whether medullary respiratory circuitry is also affected. idiopathic PD.
Since supraspinal functional map changes have been reported in other Supported by NS052414, DA15760, DA024923, and the Kenneth motor systems following SCI, we tested the hypothesis that a high Douglas Foundation.
cervical lateralized hemisection (C2Hx) will alter representation of brain stem respiratory neuronal activity. Adult female rats received in which inspiratory activity recording sites were more frequently repratory input to phrenic motoneurons (PhMNs), resulting in severe resented caudally and expiratory activity sites increased rostrally. At impairment of diaphragm function. Experimentally, this has been 12 weeks postinjury, the rostral area of where expiratory activity has extensively illustrated by a lateralized C2 spinal hemisection (C2Hx) been detected had expanded caudally. Furthermore, there was a model, which results in paralysis of the ipsilateral hemidiaphragm.
decrease in the number of sites at which inspiratory activity could be While some spontaneous diaphragm recovery has been demonstrated, detected. These findings may reflect changes in ventilatory behavior, the extent of recovery remains limited. The present work aims to as well as compensation in spinal respiratory motor function. improve the extent of recovery using a cell transplantation approach.
Supported by NIH RO1 NS054025 (P.J.R.), the Anne and Oscar A primary goal of these studies was to also determine whether donor 
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The exact roles for the two types of endogenous CX3CL1 (soluble these stores and attenuate WBH-induced brain damage. Previous studies in our lab showed that pretreatment with cerebrolysin 2.5 ml/kg and membrane-bound fracktaline) in neurodegenerative pathophysiology remain elusive. Recent literature suggests an anti-inflammatory before the onset of WBH significantly reduced brain pathology, blood-brain barrier (BBB) breakdown, and edema formation. How-and thus neuroprotective role for supraphysiological levels of exogenous soluble CX3CL1 peptide. However, it has been difficult to delin-ever, postapplication of cerebrolysin after WBH was ineffective in inducing neuroprotection. There are reports that nanowired delivery of eate the function of the soluble and membrane-bound forms of CX3CL1, as both are natively present in the brain. As such, we exam-drugs potentiates the effect of parent compounds and also the drug remains active within the CNS for a long time due to slow metabolism. ined each form's ability to regulate neuroinflammation in a mouse model of Parkinson's disease initiated by the neurotoxin 1-methyl-4-It appears that nanowired cerebrolysin might have some better therapeutic efficiency in reducing brain damage even administered at differ-phenyl-1,2,3,6-tetrahydropyridine (MPTP). We were able to delineate the function of both CX3CL1 forms by using adeno-associated virus ent time intervals after WBH. For this purpose, titanium (TiO 2 ) nanowires were used to tag cerebrolysin and the nanowired drug deliv-(AAV)-mediated gene therapy to selectively express synthetic variants of CX3CL1 that remain permanently soluble (sFKN) or membrane ery was done in a dose of 2.5 or 5 ml/kg IV at 30, 60, 90, or 120 min after WBH in rats. In these animals BBB permeability, brain edema, bound (mFKN). Briefly, three groups of 12-16-week-old male CX3CL1-null mice (n = 30 per group) were injected with mFKN, solu-and neuronal injuries were examined. The results show that nanowired delivery of cerebrolysin in low doses induced pronounced neuropro-ble sFKN, or rAAV-expressing green fluorescent protein (GFP) for a viral and protein control, while C57BL/6 (wild-type; WT) mice were tection if administered 30-60 min after WBH. However, high doses of nanowired cerebrolysin (5 ml/kg) achieved significant neuroprotection injected with sterile saline (WT, n = 60). Mice from each rAAV group received bilateral direct injections into the substantia nigra pars com-when administered even 90 or 120 min after WBH. On the other hand, normal cerebrolysin in identical doses was ineffective in reducing pacta (SNpc) using a CED 26-gauge needle. The group of WT mice received sterile saline via the same injection parameters. Six weeks brain damage administered either 30 or 90 min after WBH. These observations suggest that nanowired cerebrolysin is the most effective following SNpc injections, sFKN, mFKN, GFP-treated CX3CL1-null mice, and WT mice were serially injected IP with MPTP (10 mg/kg therapy for protecting hyperthermia-induced brain damage. In addition, nanowired cerebrolysin is also able to reduce brain damage if body weight, 4 injections, with 1-h interval) or sterile saline as an injection control. Five days after IP injections, all mice were analyzed given at different time periods after WBH. This indicates that cerebrolysin may have promising therapeutic potentials for treating brain dys-for motor coordination using a rotarod apparatus. Following behavioral analysis, animals were randomly divided for either perfusions or function in heat-related illnesses. This presentation is very timely to show how nanowired drugs could enhance therapeutic strategies to biochemical analyses. Here we show that the CX3CL1-null mice that received sFKN had reduced impairment of motor coordination, less treat CNS injuries, even administered various times after the insult in situations of whole body hyperthermia. Thus, the data may have exacerbation of dopaminergic (DA) neuron loss, as well as ameliorated microglia activation (CD11b and CD68) and proinflammatory cyto-immense clinical value that could be applied in humans exposed to high ambient temperatures for combat or other stressful situations. kine [tumor necrosis factor-α (TNF-α) and interleukin-1B (IL-1B)] release, resulting from MPTP exposure. Conversely, CX3CL1-null mice that received mFKN had a phenotype similar to CX3CL1-null Conus Venom Screening to Identify Novel Cannabinoid Receptor GFP-injected mice. To this point, both groups of mice (mFKN and Agonists for Gene Therapies in Pain Modulation GFP) had significant impairment of motor coordination, exacerbated loss of DA neurons, as measured by tyrosine hydroxylase (TH) and C. Perez, S. Jergova, D. Collante, S. Gajavelli, and J. Sagen NeuN immunoreactivity. Furthermore, microglia activation (CD11b and CD68) was significantly upregulated in mFKN and GFP groups University of Miami, Miller School of Medicine, Miami Project, compared to sFKN. Lastly, there was a significant upregulation of both Miami, FL, USA TNF-α and IL-1B in mFKN-and GFP-treated mice. Together, mFKN-Chronic neuropathic pain significantly affects the quality of life of treated mice phenotypically resembled mice injected with GFP for all peripheral nerve injury or spinal cord injury patients. With low effimeasurable outputs, suggesting that the full-length membrane-bound cacy of current pharmacotherapy for chronic pain, the identification of form of CX3CL1 is insufficient in providing the anti-inflammatory alternative approaches and new therapeutic targets is essential. effects associated with CX3CL1. As such we conclude that the soluble The venoms of marine snail genus Conus are a natural source of CX3CL1 is the anti-inflammatory and microglia-calming agent in a various peptides ( Therefore, specific compounds interacting with CB receptors without The possibility that nanowired cerebrolysin, a mixture of different neurotrophic factors [e.g., brain-derived neurotrophic factor (BDNF), aversive side effects are of clinical interest. In this study we evaluated the ability of several Conus venom extracts to interact with CB1 recep-glial-derived neurotrophic factor (GDNF), nerve growth factor (NGF), ciliary neurotrophic factors (CNTF)] and other active peptides, will tor. The venom extracts of six Conus species were analyzed in vitro. HEK293 cells expressing CB1 were treated with venom extracts for be more efficient in inducing neuroprotection following hyperthermiainduced brain injury compared to normal cerebrolysin was examined 30 min, fixed, and immunostained. Internalization of CB1 receptor was evaluated using fluorescence immunocytochemistry and confocal in this investigation. Whole body hyperthermia (WBH) was induced in rats by exposing them in a biological oxygen demand incubator imaging or high content screening. Results showed the highest rate of CB1 internalization in HEK293 cells after treatment with venoms of (BOD) at 38°C for 4 h. This experimental condition induces profound cellular damage in the brain. Since brain injury depletes endogenous C. textile and C. miles. HPLC fractions (seven per species) of these venoms were subsequently analyzed using a similar approach. Based sources of neurotrophins, it is likely that cerebrolysin could replace on the analysis, two subfractions with the highest CB1 agonist activity lineage specific. Additionally, the number of SC121 + cells not labeled by any of these three lineage markers exhibited a positive correlation were evaluated in a formalin test after their intraperitoneal (IP), intrathecal (IT), or intracerebroventricular (ICV) injection. IT injection with the number of engrafted SC121 + cells (Pearson r = 0.6, two-tailed p = 0.003), suggesting increasing cell dose may alter the kinetics of of the C. tex fraction reduced flinching/licking behavior during the second phase of a formalin test and ICV injection of the C. mil fraction differentiation. No aberrant histological findings were observed in any transplanted spinal cords, regardless of dose. These preliminary data reduced behavior during the first phase. The results indicate the presence of CB1 agonists within the Conus venom extract and their poten-suggest a possible correlation between cell dose and/or fate/differentiation kinetics in the injured spinal cord, but overall, similar patterns tial analgesic effects. The identification of the single analgesic agents with CB1 agonist activity within the selected venom fractions is in the of survival, fate, and migration were observed in the injured spinal cord at transplantation doses ranging from 10,000 to 500,000 cells. progress. The final peptide compounds of screened venoms with CB1 receptor affinity could subsequently be used as a new analgesic agent in recombinant cell or gene therapy approaches.
NPCs (Bjugstad et al., Cell Transplantation, 14:183; 2005) . ¶StemCells Inc., Newark, CA, USA However, there are many disorders that are present from birth and that continue into adulthood and aging, such as Down syndrome (DS). We have previously shown that human central nervous systemderived stem cells (hCNS-SCs) promote locomotor recovery after spi-How NPC-based therapies might also benefit these conditions is unknown. Using a DS mouse model, we sought to answer the question nal cord injury (SCI) by integrating into host tissue, and that the majority of the hCNS-SCs differentiated into oligodendrocytes when of NPC longevity. Ts65Dn trisomic mice (DS modeling) and their disomic littermates (normal controls) were implanted into the hippo-75,000 cells were transplanted into the spinal cord 9 or 30 days post-SCI (Cummings, 2005; Hooshmand, 2009; Salazar, 2010) . In these campus on postnatal day 2 (PND2) with NPCs, saline, or remained untreated. Twelve months later, all mice were tested for cognitive studies, the total number of surviving cells was positively correlated with improvements in functional recovery (Hooshmand, 2009 ). How-function, the long-term survival of NPCs, hippocampal cell numbers, and the presence of extracellular tau accumulation. We previously ever, the capacity of the injured spinal cord niche to accommodate donor cells and provide sites and cues for cell differentiation and/or reported on the cognitive outcomes. Briefly, the implantation of NPCs in trisomic mice improved performance on the conditioned taste aver-integration may be limited. In this study, we investigated the association between cell dose (i.e., the number of transplanted hCNS-SCs) sion, but not on the novel object recognition task. Trisomic mice given saline control injections improved performance on both cognitive and engraftment, survival, or differentiation by transplanting 10,000, 100,000, 250,000, or 500,000 cells into the spinal cords of nonobese tasks. Disomic mice, implanted with either saline or NPCs, appeared impaired in both tasks. The current presentation reports on the survival diabetic severe combined immunodeficient (NOD-scid) mice after moderate (50 kDa) midthoracic (T9) contusion SCI at an early chronic of the NPCs and long-term changes in the hippocampus of these aging mice. Surviving NPCs were found in the brains of both disomic and stage 30 days postinjury. At 16 weeks posttransplantation, unbiased stereological quantification of hCNS-SCs using a human-specific cyto-trisomic mice, but rarely at the site of implantation, the hippocampus. Most NPCs were found in the subventricular zone (SVZ) and sur-plasmic marker (SC121) demonstrated that the number of engrafted cells was positively correlated with the transplanted cell dose in each rounding areas (e.g., striatum and septum). No hypocellularity in CA1, CA3, or the dentate gyrus was found in hippocampus of trisomic mice. group (Pearson r = 0.79, two-tailed p < 0.0001); that is, a linear relationship was observed between initial transplant dose and the esti-Both implantation procedures, though, tended to reduce the number of hippocampal neurons in disomic and trisomic brains. Hippocampal mated total number of surviving cells determined at 16 weeks posttransplantation. Engraftment and survival were observed across all cell numbers were not correlated with cognitive performance. Extracellular tau aggregations were found with greatest frequency in the dose cohorts; however, the ratio of surviving cells relative to the initial cell dose was noted to be significantly higher in the low-dose group stratum lacunosum-moleculare in CA1, compared to other areas in the hippocampus or brain. Trisomic brains had significantly more extra-when compared to the other dose cohorts (one-way ANOVA, Tukey's test p < 0.05). hCNS-SCs transplanted at all doses showed normal cellular tau aggregations than the disomic brains. Brains that were implanted with NPCs, regardless of evidence for survival 12 months migration from the injection sites into the parenchyma. Quantification of hCNS-SC differentiation revealed that the majority of cells differen-later, were associated with fewer extracellular tau aggregations. This was found to be true in both disomic and trisomic brains. Saline injec-tiated into SC121 + /Olig2 + oligodendrocytes/oligoprogenitors, regardless of the dose group, and that the total number of SC121 + /Olig2 + tions significantly elevated tau presence in both karyotypes. In light of the saline implantation-induced changes, and the lack of a clear cells was greater in higher dose than lower dose groups. However, the proportion of SC121 + /Olig2 + cells varied from 82 ± 7% in the 10,000 benefit of NPCs, we conclude that the effects of NPCs cannot be distinguished from those induced by the implant procedure. Further, these cell dose group to 56 ± 4% in the 500,000 cell dose group when normalized to the total number of surviving SC121 + cells. Statistical anal-effects, while initiated neonatally, have long-term consequences. An alternative route of NPC administration, which enhances cell survival ysis revealed that the number of engrafted SC121 + cells and SC121 + / Olig2 + cells exhibited a negative correlation (Pearson r = −0.62, two-and minimizes implant injury to the brain, may be advisable to separate out discrete NPC effects. tailed p = 0.002). In contrast, no correlation was found between the number of engrafted SC121 + cells and number of either SC121 + /dou-This work was supported by a Ruth L. Kirschstein National Research Service Award (NRSA) (F31NS060517), The Anna and John blecortin (DCX + ) neural progenitors (7 ± 1.2%) or SC123 + human astrocytes (15 ± 1.5), suggesting the effect of cell dose on fate was J. Sie Foundation, and The Linda Crnic Institute.
A Comprehensive Description of the Progressive Pathology administered to presymptomatic (9 weeks old) and symptomatic (13 weeks old) G93A SOD1 mice. The multiple 10 6 cell doses in presymp-Exhibited by the R6/2 Transgenic Mouse Model of Huntington's Disease tomatic and 2.5 × 10 6 cell doses in symptomatic mice were found to delay motor functional deterioration, extend life span, and reduce microglial responses compared to vehicle-treated mice. A single intra-I. Rattray,* R. Gale, † E. Smith,* K. Matsumoto,* G. Bates, † venous administration of 3 × 10 6 HUCBCs into 3-month-old α-N-aceand M. Modo* tylglucosaminidase (Naglu) knockout mice (an animal model of MPS III B caused by deficiency of the enzyme Naglu), modestly improved *Institute of Psychiatry, King's College London, London, UK the behavioral outcomes, reduced heparin sulfate accumulation, and †Medical and Molecular Genetics, King's College London, London, UK modified inflammation compared to vehicle-treated mice. By compari-The R6/2 transgenic mouse line exhibits a rapid onset of Huntingson, multiple same dose cell injections, given monthly for 6 months, ton's disease (HD)-like symptoms. The current study provides a interwere found to lead to prolonged benefits in behavior, greater cell disciplinary, longitudinal description of the progressive pathology migration into the brain, and reduced heparin sulfate accumulation verexhibited by this model. For this purpose, both male and female R6/2 sus mice given a single cell dose. These studies show that multiple mice along with wild-type littermate controls were repeatedly assessed low doses of HUCBCs administered intravenously are more beneficial on a variety of functional measures, including motor performance on than a single high cell dose. The use of multiple injections is likely to an accelerating rotarod, anxiety-like behavior, and locomotor activity provide long-term benefit against the progressive nature of these disin an open field, as well as cognitive performance in the passive avoideases, by providing sustained replacement of the Naglu enzyme in ance test. Alongside this behavioral characterization, we have imple-MPS III B as well as long-term trophic support against the progressive mented serial in vivo MRI for studying age-related changes in brain degeneration in AD and ALS. In addition, use of smaller doses will atrophy and tissue T2 relaxometry. Scanning was conducted at 4, 8, be easier to translate into the clinical setting. These studies therefore 12, and 14 weeks of age and was separated by the behavioral assays.
provide the groundwork for more comprehensive investigation to opti-To support these in vivo measures, postmortem quantification of neumize the frequency and size of multiple injections in relation to their ropathological markers including stereological neuronal cell counts safety and clinical translatability for these and potentially other neuroand mutant huntingtin protein expression have been taken. Marked degenerative diseases. abnormalities were observed in the R6/2 mice, including the develop-P.R.S., S.G.D., J.T., C.V.B., and L.E.C. are founders and/or conment of deficits at the rotarod and an escalating hypoactivity in the sultants of Saneron CCEL Therapeutics. L.E.C. is Founder and P.R.S. open field. A progressive atrophy in a variety of brain regions was is consultant of Cryopraxis Criobiologia Ltda. These projects were evident alongside a shortening of T2 relaxation times. We will perform funded in part by the Children's Medical Research Foundation and a correlative analysis with the aim of linking changes in behavioral the NIH. phenotypes with the development of brain abnormalities. This investigation will provide crucial information regarding the neurobiological Intraspinal Transplantation of Neural Progenitors Improves underpinnings of brain atrophy in the R6/2 mice and how these relate Diaphragm Function Following Midcervical Contusion Injury to the emergence of behavioral impairments. ing. This is due primarily to disruption of bulbospinal respiratory fiber pathways and direct loss of phrenic motoneurons (PhMNs) and pre-*Center of Excellence for Aging and Brain Repair, Department phrenic interneurons. A consistent respiratory outcome of C3-C5 of Neurosurgery and Brain Repair, University of South Florida contusions in rodents is chronically diminished diaphragm EMG Morsani College of Medicine, Tampa, FL, USA (diaEMG) responses to respiratory challenge (e.g., hypercapnia). †Cryopraxis Criobiologia Ltda, Rio de Janeiro, Brazil
Recent experimental studies have shown that this deficit may be due ‡Saneron-CCEL Therapeutics, Tampa, FL, USA primarily to gray matter damage. Therefore, the present study will test the hypothesis that restitution of gray matter integrity following mid-Cell therapy has great potential for the treatment of neurodegenerative diseases. The mononuclear cell fraction from umbilical cord cervical contusion injury will improved diaphragm function. Lateralized C3/4 contusions were produced in adult female rats using the blood (HUCBCs) is a heterogenous population, including stem cells, lymphocytes, and monocytes, and provides benefit following a single Infinite Horizon Impactor (200 kilodyne preset force), and the animals were divided into treated and untreated groups. One week postinjury relatively high intravenous dose in animal models of Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and Sanfilippo syn-in treated animals, dissociated E13.5-14 fetal spinal cord (FSC) tissue was injected into the lesion epicenter. Animals were allowed to drome type B (mucopolysaccharidosis III B; MPS III B). Very few (if any) of these injected cells remain inside and outside of the CNS a recover for 1 month posttransplant. At that time, pseudorabies virus (PRV) was applied directly to the diaphragm or injected into the site few months after a single injection. This, in conjunction with the progressive nature of these diseases, suggests that repeated injections of of transplantation, to establish connectivity between 1) donor neurons and the host phrenic circuit and 2) host and donor neurons. Terminal lower cell doses may prove to be more effective than a single dose. Using 7-month-old transgenic PSAPP and Tg2576 mice as models of EMG recordings were made in spontaneously breathing animals to assess ipsi-and contralateral diaphragm activity under baseline (eup-AD, 100,000 HUCBCs were administered intravenously every 2 weeks for 2 months and then monthly for an additional 4 months. neic breathing) and challenge (exposed to hypercapnia) conditions. While diaphragm activity usually increases during respiratory chal-Multiple injections of this low dose of HUCBCs were found to reduce amyloid accumulation and associated astrogliosis as well as attenuate lenge, all injured untreated animals exhibited blunted ipsilateral EMG responses to respiratory challenge 5 weeks postinjury. In contrast, CD40L-induced inflammatory responses to a greater extent than seen in mice treated with either a single higher dose of HUCBCs (5 × 10 6 ) graft recipients showed elevated EMG activity during challenge. PRV delivered to the ipsilateral hemidiaphragm resulted in infection of the or vehicle. A single dose of intravenously administered HUCBCs (25 × 10 6 ) into presymptomatic G93A SOD1 mice (an animal model of PhMN pool and second-order host interneurons, as well as labeling of a contingent of donor neurons. Intragraft injection of PRV resulted in ALS) was found to be optimal for delaying the disease progression, extending the life span and decreasing proinflammatory cytokines in labeling of host interneurons in the vicinity of the grafts. Additional immunohistochemical analyses revealed enlarged astrocytes surround-these mice. Since the equivalent dose in humans is unlikely to be feasible, multiple weekly injections of 10 6 or 2.5 × 10 6 HUCBCs were ing the donor tissue and both rostral and caudal to the site of injury/ transplant in the host spinal cord. These data demonstrate that restora-effects on pathology, seeking to find the most effective agent to pursue further, ideally to clinical trial. In these experiments, we examined the tion of gray matter integrity by spinal interneuronal progenitors can ameliorate an aspect of postcervical SCI respiration, even in the pres-acute results of intracranial administration of antibodies to three different "classes" of tau pathology: PHF-1, which recognizes hyper-ence of substantial astrocytic accumulation and activation. Our neuroanatomical findings further suggest this functional change is mediated phosphorylation at Ser396/404; MC-1, an antibody that detects conformational changes of tau protein; and DA 9, a pan-tau antibody by bidirectional connectivity between donor neurons and host interneurons and PhMNs.
that may detect and/or interact with both normal and pathological forms of tau. All of these were compared to anti-GFP control antibody Supported by NIH RO1 NS054025 (P.J.R.) , the Anne and Oscar Lackner Chair in Medicine (P.J.R.) , and the Brain & Spinal Cord administration, an identical isotype that is not known to be biologically active. We used the rTg4510 mouse model, as it is known for inducing Injury Research Trust Development Funds (M.A.L.) .
robust tau pathology in cortical and hippocampal areas relevant to AD and other dementias; 30 mice were divided into four groups of 7-8.
Targeted Gene Editing in Rod Photoreceptor Cells In Vivo
Each group received unilateral intracranial injection of one of the antibodies listed above, into the right anterior cortex and hippocampus. I. M. Sandoval,* F. Chan,* B. A. Price,* A. K. Gross, †
The left hemisphere was left untreated as an internal control for extent W. W. Hauswirth, ‡ T. G. Wensel,* and J. H. Wilson* of tau deposition. Four days postinjection tissue was collected for immunohistochemical analysis and future biochemistry. The following *Biochemistry and Molecular Biology, Baylor College of Medicine, histochemical techniques were conducted to assess the effect of the Houston, TX, USA antibodies: Gallyas silver stain, Nissl stain, and immunocytochemical †Vision Sciences, University of Alabama at Birmingham, staining for H150, pSer199/202, pSer396, and CD45. Both MC-1 and Birmingham, AL, USA DA 9 reduced pathology as indicated by some of the markers tested, ‡Ophthalmology and Molecular Genetics, University of Florida, whereas PHF-1 did not appear to significantly reduce tau pathology. Gainesville, FL, USA Based on the results presented here, we are inclined to pursue MC-1 Targeted gene editing is a promising potential therapy to treat further as a treatment of choice. many devastating genetic diseases caused by dominant mutations. The
Supported by NS076308. strategy requires the introduction of a double strand break at a target site in the genome. Bone marrow-derived cells (BMDCs) of the monocyte/macroevents. In retinas containing an allele with a duplication of one exon phage lineage include two subtypes: "resident" (expressing CCR2 neg , (ID2) that causes a frame shift, treatment with recombinant adeno-CX3CR1 hi ) and "inflammatory" (CCR2 hi Ly6C + ). Macrophages and associated virus (rAAV) expressing endonuclease Isce1 led to a dramicroglia become activated through two activation states: M1, which matic increase in GFP-positive cells, about 15% of all cells in the incites tissue damage and promotes proinflammatory cytokine profiles, injected area. Sequence analysis revealed that double strand breaks and M2, which promotes wound repair and dampens proinflammatory (DSBs) in these cells were repaired by HR, while those in the nonfluopathways. We examined whether cytokine-induced M1 versus M2 rescent cells were repaired by NHEJ. Mice bearing nonsense mutations activation promote recruitment and infiltration of peripheral monothat cause retinitis pigmentosa in humans, Q64X and Q344X, had low, cytes into the CNS, and which subtype(s) of monocytes respond to M1 and strikingly different, frequencies of spontaneous correction, 10 −7 versus M2 stimulator cocktails. To do so, we transduced endogenous and 10 −6 , respectively. The overwhelming majority of these occurred BMDCs with green fluorescent protein (GFP) by intraosseous injecin individual cells rather than pairs or clusters, indicating the mutation tions of recombinant adeno-associated virus (serotype 9; rAAV9). happened after the last mitosis, and the frequencies did not increase Mice received injections of rAAV9-GFP bilaterally into both femurs. significantly with age. Since the 5′ untranslated regions of the tran-Three weeks later, mice received an intracranial injection of either scription units were engineered for low translation levels, the retinas an M1 cytokine cocktail [tumor necrosis factor-α (TNF-α), 667 ng; do not undergo degeneration, so they are a powerful tool for investiinterleukin-12 (IL-12), 26 ng; and IL-1β, 26 ng], an M2 cytokine cockgating the ability of treatments, such as rAAV encoding zinc-finger tail (IL-4, 800 ng and IL-13, 240 ng) or vehicle (PBS). Brain and endonucleases designed to cut near the mutation sites, to effect gene bone marrow were analyzed by flow cytometry for GFP expression, repair. microglia/macrophage markers, and "inflammatory" markers (CCR2 hi , Ly6C + ) 3 days later. In bone marrow tissue [after red blood cell (RBC) Intracranial Administration of Antibodies Directed Against Tau: lyses] rAAV9-GFP transduced 4% of the total BMDC population.
A Potential Therapy for Alzheimer's Disease
Forty percent of the BMDCs expressed Ly6C, 5% were labeled as CCR2 hi , 10% versus 3% were labeled as CD45 + and CD11b + , respec-S. Schroeder,* † M. N. Gordon,* † and D. Morgan* † tively. In brain tissue, M1 stimuli significantly induced recruitment of GFP + cells into the brain compared to M2-and vehicle-injected ani-*USF Health Byrd Alzheimer's Institute, University of South mals. M1 cytokine cocktail, but not M2 cocktail, increased Ly6C + , Florida, Tampa, FL, USA CD11b + , and CD45 + expression in brain microglia. M1 activation †Department of Molecular Pharmacology and Physiology, University induced recruitment and infiltration of an "inflammatory" subset of of South Florida, Tampa, FL, USA peripheral monocytes because the GFP + /Ly6C + population was increased only in this group. However, both M1 and M2 activation of Immunotherapy, as a potential for treating, or maybe even preventing, Alzheimer's disease (AD) has been extensively studied, primarily microglia induced increases in CCR2 expression within brain microglia, indicating activation of brain microglia due to M1/M2 stimuli. with A-β as the target protein, leading to a number of clinical studies. Recently, tau pathology has been receiving more attention as a thera-Next, we will use immunohistochemistry to determine the functional state the transduced GFP + cells that homed into CNS by staining for peutic target for immunotherapy, especially due to the stronger correlation between tau pathology and cognitive deficits. In this series of markers of M1 (IL-1β, Marco) versus M2 (YM1, Arg-1) activation. Overall, these experiments will identify specific inflammatory stimuli experiments we have tested multiple antibodies against tau for their 790 ABSTRACTS that enhance recruitment and infiltration of endogenous inflammatory neurological dysfunctions. Hypertension was produced in rats (200-250 g) by 2-kidney one clip (2K1C) method causing elevation of mean monocyte subsets into CNS.
Supported by NIH grant AG015490. arterial blood pressure (MABP) by 20 ± 6 mmHg after 1 week and 40 ± 5 mmHg after 4 weeks. In these rats, SiO 2 nanoparticles (50-60 nm) were administered 50 mg/kg, IP, once daily for 1 week and then sub-Sigma Receptor (Rs) Agonist NAPH Decreased Long-Term jected to partial restraint in a Perspex box restricting their movement Infarct Volume and Rescued White Matter After Middle for 4 h either at room temperature (21°C) or at 33°C in a biological Cerebral Artery Occlusion (MCAO) oxygen demand incubator (BOD, wind velocity 2.6 cm/s, relative humidity 65-67%). In these animals, behavioral functions, blood-M. Shahaduzzaman,* J. McAleer,* J. Grieco,* J. Golden,* brain barrier (BBB) permeability to Evans blue albumin (EBA) and J. Glover,* J. Hall,* M. Cortes-Salva, † J. Antilla, † J. Cuevas, ‡ radioiodine ( 131 iodine), brain water content, and neuronal injuries were K. R. Pennypacker, ‡ and A. E. Willing* ‡ determined. Hypertensive rats subjected to 4-h restraint at room temperature did not exhibit BBB dysfunction, brain edema, neural injury, *Center for Excellence in Aging & Brain Repair, Department or alterations in Rotarod or inclined plane angle performances. Howof Neurosurgery and Brain Repair, University of South Florida, ever, when these hypertensive rats were subjected to restraint at 33°C, Tampa, FL, USA breakdown of the cortical BBB (EBA +38%, radioiodine +56%), brain †Department of Chemistry, University of South Florida, water (+0.88%), neuronal damages (+18%), and behavioral impair-Tampa, FL, USA ment were much more exacerbated. Interestingly, SiO 2 exposure to ‡Molecular Pharmacology and Physiology, University of South these hypertensive rats further exacerbated breakdown of the BBB Florida, Tampa, FL, USA (EBA 280%, radioiodine 350%), brain edema (4%), and neural injury In humans, white matter comprises about 50% of brain volume (30%) after restraint stress depending on the ambient temperature. and is adversely affected in most cases of stroke. In rodents, white SiO 2 treatment also induced brain pathology and alteration in behavmatter constitutes only 14% of brain volume and most animal stroke ioral functions in normotensive rats after restraint at high temperature, models have largely neglected the study of white matter injury after a feature not seen in saline-treated normotensive or hypertensive rats. stroke. Oligodendrocytes are more sensitive to excitotoxicity and oxi-These observations clearly show that hypertension significantly dative stress than neurons, so a drug targeted only to gray matter will enhances restraint-induced brain pathology and behavioral anomalies, not necessarily be efficient in minimizing damage or enhancing recovparticularly at high ambient temperature and SiO 2 intoxication further ery after stroke. In our previous study, we report that Sigma1 and 2 exacerbate these brain damage and cognitive dysfunctions. receptor (σ1/σ2Rs) agonist [1,3 di-o-tolylguanidine (DTG)] treatment decreased short-term infarct volume when administered 24 h post-Posttreatment of Stroke With Cocainestroke, but the effect was not maintained over the long term and thereand Amphetamine-Regulated Transcript fore did not improve behavioral outcomes (Leonardo et al., 2010) . In the present study we administered a newly synthesized mixed σ1/σ2Rs H. Shen, Y. Luo, H-S. Liu, S. J. Yu, Y. Yang, B. J. Hoffer, agonist, N′N-di-NAPH-HCL (NAPH), which is based on the structure and Y. Wang of DTG. The present study examines long-term therapeutic effects of this compound on infarct volume and white matter as well as neurobe-Neural Protection and Regeneration Section, National Institute havioral outcomes. Male Sprague-Dawley rats were divided into two on Drug Abuse, Baltimore, MD, USA groups (n = 16/group) receiving either daily subcutaneous injections of Current pharmacological treatments for stroke are limited by a nar-NAPH or vehicle for 3 days starting at 24 h poststroke. Our results row therapeutic time window. We here describe a delayed, noninvademonstrated that infarct volume in the stroke group receiving vehicle sive poststroke therapeutic approach involving functional recovery only (n = 10) was 30.49 ± 8.71%, whereas animals receiving NAPH after stroke. Rats were treated with cocaine-and amphetamine-regu-(n = 12) showed infarcts involving only 13.93 ± 3.79% of the hemilated transcript (CART), delivered into the nostrils, from day 3 after sphere 30 days poststroke. We also observed that NAPH protects white middle cerebral artery occlusion. CART treatment improved behavmatter from stroke-induced lesions, suggesting that NAPH exerts its ioral recovery and reduced neurological scores. In the subventricular neuroprotective effects via preservation of both gray matter and white zone (SVZ), CART enhanced immunolabeling of bromodeoxyuridine, matter tracts. Future studies will examine in vitro effects of NAPH on the neuroprogenitor cell (NPC) marker Musashi-1, and the proliferatoligodendrocyte (OL) apoptosis. This study demonstrates that NAPH ing cell nuclear antigen, as well as upregulated brain-derived neuroreduces infarct volume and protects white matter from stroke-induced trophic factor (BDNF) mRNA. Overexpression of BDNF by local lesion, and σRs may prove to be a valuable therapeutic target for stroke.
administration of AAV-BDNF in SVZ enhanced migration of SVZ This study was supported in part by James and Esther King Florcells toward the ischemic cortex and induced behavioral improvement. ida Biomedical Team Science Program #09KT-02.
In SVZ culture, CART increased neurosphere formation and cell migration. CART-mediated cell migration was significantly antago-Exacerbation of Stress Symptoms, Sensory Motor Dysfunction, nized by anti-BDNF blocking antibody, suggesting this response is and Brain Pathology After Partial Restraint in Hypertensive mediated through BDNF. Diffusion-tensor imaging and 1 H-magnetic Rats Following Silica Dust (SiO 2 Nanoparticles) Exposure at resonance spectroscopy were used to examine reinnervation in the High Ambient Temperature lesioned cortex. Significant increases in the fractional anisotropy ratio and N-acetylaspartate levels were found in the lesioned cortex after H. S. Sharma,* D. F. Muresanu, † R. Patnaik, ‡ and A. Sharma* CART treatment. Western analysis indicated that CART significantly increased the expression of growth-associated protein 43 in the *Laboratory of Cerebrovascular Research, Department of Surgical lesioned cortex. Taken together, these data suggest that CART Sciences, Anesthesiology & Intensive Care Medicine, University enhances reinnervation in the lesioned cortex. In conclusion, post-Hospital, Uppsala University, Uppsala, Sweden stroke intranasal treatment with CART facilitates behavioral recovery, †Neurology, University of Medicine & Pharmacy, which is associated with proliferation and migration of NPCs from Cluj-Napoca, Romania SVZ and an increase in neural innervation in the lesioned cortex. Our ‡Institute of technology, Banaras Hindu University, Varanasi, India results may provide a new treatment strategy for stroke patients, The possibility that exposure of silica dust to hypertensive individenabling a noninvasive and longer treatment window of days after uals may exacerbate brain pathology and sensory motor dysfunctions, stroke occurrence. particularly at high environmental temperature, was examined in this investigation. Since military combat operation is often associated with both psychological and physical stress resulting in hypertensive episodes, it is quite likely that additional exposure of silica at high environmental temperature will further deteriorate hypertension induced
The Face of Stress in Stroke: Pain Response and DNA Damage
Here we report our analysis in nonhuman primates of the feasibility of applying CED technology for the delivery of AAV5 encoding for in the Thymus of Adult Rats Exposed to Experimental Stroke glial-derived neurotrophic factor (GDNF) or green fluorescent protein (GFP). Adult rhesus monkeys were screened for the presence of anti-K. Shinozuka, N. Tajiri, N. Weinbren, Y. Kaneko, bodies against AAV5. Four seronegative animals were selected, and and C. V. Borlongan underwent baseline MRI and angiography for evaluation of anatomy and targeting purposes. Two animals received a high dose (1E11 gc Center of Excellence for Aging & Brain Repair, Department per injection) and the other two a low dose (1E10 gc per injection) of of Neurosurgery and Brain Repair, University of South Florida AAV5 encoding for GDNF into the right ventral postcommisural puta-Morsani College of Medicine, Tampa, FL, USA men and for GFP into the contralateral hemisphere. Each vector inocu-Stress has been implicated as a major exacerbating factor of stroke lation (one per hemisphere) had a volume of 30 µl, and it was pathological manifestations, including immune response. The present performed under intraoperative MRI monitoring using CED methods study was designed to investigate the interaction between stroke and (rate of infusion: 1 µl/min). Six weeks after surgery the animals were stress, with the latter characterized behaviorally by a novel pain pernecropsied and the brains removed and processed. Evaluation of ception scale, and cellularly by DNA damage in the thymus, an imporimaging obtained during surgery, as well as postmortem analysis of tant organ for immune defense system (i.e., T-lymphocyte maturation).
intracerebral expression of GDNF and GFP, confirmed accurate and Fifteen Sprague-Dawley rats received middle cerebral artery occlusion replicable targeting of the postcommissural putamen nucleus in all (MCAo) to induce experimental stroke. Thirteen rats served as intact monkeys. Distribution beyond the target was titer dependent. Retrocontrol subjects. Routine behavioral and histological assays were pergrade transport of both recombinant proteins into the substantia nigra formed to determine stroke symptoms. For characterization of stress, was observed at the two titer levels. Quantification of dopaminergic the subjects were videotaped for 15 min at 1 day before and 0, 1, and markers revealed increased striatal and nigral TH optical density 3 days after MCAo. After video recording at day 3, all animals were immunoreactivity in the side ipsilateral to GDNF treatment, suggesting sacrificed and their thymus collected. Subjects' pain perception, which its biological activity. Although stereological cell count of TH-positive is considered as one of the poststroke stressors, was analyzed from the nigral neurons did not reveal differences between treatments and titers, video in accordance with Rodent Grimace Scale (Longford et al., nigral neuronal volume was greater in the side ipsilateral to GDNF 2010; Sotocinal et al., 2011) . DNA damage in the thymus was anacompared to GFP, hinting at a biological effect of GDNF. Our results lyzed by immunostaining with gamma-histone 2a (H2AX) antibody, suggest that application of intraoperative MRI-guided CED for gene which is known as a DNA double strand break marker. Stroke animals transfer is an accurate and replicable method of targeting that facilidisplayed the characteristic motor asymmetry and cerebral infarction, tates viral vector distribution and efficacy to deliver a therapeutic whereas intact control subjects exhibited normal behaviors and nondetransgene. Additional molecular biology analysis of GDNF and GFP tectable pathological damage to the brain. Pain scores before MCAo expression is currently under way. revealed no significant differences across groups. Following MCAo, Supported by P51 RR000167 (NIH-NCRR) , to the Wisconsin significant treatment effects on pain scores were detected. Stroke sub-National Primate Research Center, University of Wisconsin-Madison, jects showed significantly higher pain score than those in intact NIH-NIHMS P32 GM007507 (J.A.S.). This research was conducted in subjects (p < 0.05). Gamma-H2AX-immunoreactive cells were localpart at a facility constructed with support grants RR15459-01 and ized at the boundary between medulla and cortex of the thymus, and RR020141-01. were highly expressed in the stroke group compared to the control group. This is the first report extending the utility of the rodent gri-Cocrystals of Quercetin With Improved Oral Bioavailability May mace scale in a neurological condition. Here we show that the typical be Useful for Treating Neurodegenerative Disease stroke neurobehavioral symptoms produced by MCAo were accompanied by a pain response. Moreover, we demonstrate that this stroke-R. D. Shytle,* A. J. Smith,* P. Kavuru, † L. Wojtas, † induced behavioral stress response coincided with an upregulation of and M. J. Zaworotko † a cellular stress marker involving DNA damage in the thymus. These results suggest that care and management of stroke patients, at least in the acute setting, may benefit from a careful consideration of treating properties that are vastly superior to quercetin alone. Cocrystallization was able to overcome the water insolubility of quercetin, with all four Application of convection enhanced delivery (CED) to gene therapy is proposed as a method to optimize treatment delivery by maxi-cocrystals exhibiting some degree of solubility. The QUECAF and QUECAFؒMeOH cocrystals increased the solubility of QUE by 14-mizing intracerebral distribution of viral vector per inoculation, minimizing the risks associated to multiple injections sites. Several and 8-fold when compared to QUE dihydrate. We hypothesized that this improved solubility would translate into enhanced systemic adeno-associated viral vector (AAV) serotypes are currently being evaluated to deliver therapeutic transgenes to the brain. While AAV2 absorption of QUE. This hypothesis was supported in our pharmacokinetic study. The cocrystals outperformed QUE dihydrate with increases is widely used for preclinical and clinical research, other serotypes are emerging for their different cellular affinity and transfection efficacy.
in bioavailability up to nearly 10-fold. Studies are now under way to determine if these quercetin cocrystals provide better access to the survival and stimulate the regeneration of affected neurons. In spite of promising data from animal models of neuropathic pain, ARTN itself brain, and thus superior neuroprotective efficacy over quercetin alone.
The authors are inventors on patents covering the composition of is not a good pharmacological agent: it is expensive to produce and store, it does not penetrate tissue barriers, and does not diffuse much matter and use of nutraceutical cocrystals.
from the site of application (Bespalov et al., 2011) . These problems can be overcome by the development of small molecules acting simi-A Novel Lithium Cocrystal With Improved Oral Bioavailability larly to ARTN, but with significantly improved pharmacological prop-and Targeted Brain Delivery erties. We established a panel of assays to facilitate the selection of small molecular weight ARTN mimetics and screened chemical library R. D. Shytle,* A. J. Smith,* P. Kavuru, † and M. J. Zaworotko † of 30,000 drug-like compounds. We identified several molecules activating RET and its downstream targets in the cells expressing ARTN *Center of Excellence for Aging and Brain Repair, Department receptors. On the basis of active scaffolds discovered in high-throughof Neurosurgery and Brain Repair, University of South Florida put screening, a focused library of chemicals was generated and tested Health Morsani College of Medicine, Tampa, FL, USA for the ability to activate RET, MAPK, and Akt. The most potent †Department of Chemistry, College of Arts and Sciences, University molecules from the focused library were tested for their specificity of South Florida, Tampa, FL, USA towards RET, cytoxicity and ability to support survival and sprouting New research suggests that lithium is an essential trace element in of sensory dorsal root ganglion (DRG) neurons in vitro. Our results higher animals and may be an important therapeutic tool for developshow that the selected compounds do not activate another receptor ing novel stem cell therapies as well as treating neurodegenerative tyrosine kinase called TrkB (that transmits signals from ARTN-unredisease. Whereas lithium is the only medication that consistently lated neurotrophic factors) and do not significantly stimulate TrkBreduces suicide in vulnerable populations and is still considered the dependent intracellular signalling. Preliminary data demonstrate that one gold standard for treating bipolar disorder, the lithium formulations molecule efficiently promotes survival and induces neuritogenesis from currently available, such as lithium chloride and lithium carbonate, DRG in vitro. Selected compounds are also neither toxic nor survivalprovide a narrow therapeutic window due, in part, to their poor physipromoting towards non-neuronal cells (fibroblastic origin) in the concentracochemical properties and thus require routine blood monitoring to tions active on DRG neurons. Selected compounds have also demonstrated prevent systemic lithium toxicity. In an effort to develop new lithium efficacy in the Chung and Bennett rat models of neuropathic pain. compounds with improved oral bioavailability as well as selected Currently, these compounds are being tested for advanced ADME-Tox uptake by the brain over other organs, we have recently evaluated the (absorption, distribution, metabolism, excretion-toxicity) properties. pharmacokinetics of some new ionic cocrystals of lithium developed by our interdisciplinary team at USF. We will present preliminary data L-Dopa and Graft-Induced Dyskinesia from one of our compounds exhibiting vastly superior oral absorption in the 6-OHDA-Lesioned Mouse and blood-brain barrier penetration in rats. We believe that these new lithium cocrystals could potentially lower the dose of lithium needed G and other therapeutic strategies are much needed. The transplantation Helsinki, Finland of ventral mesencephalon (VM) tissue has shown encouraging results †Tallinn University of Technology, Tallinn, Estonia at clinical trial, yet a proportion of patients developed graft-induced ‡GeneCode Ltd., Tallinn, Estonia dyskinesia (GID). The mechanism of this remains unclear and needs Chronic or neuropathic pain is caused by damage of sensory neuto be elucidated to aid both the continuation of VM clinical trials and rons and affects up to one sixth of the Western population at various the initiation of new stem cell clinical trials. Deficits on behavioral times of an individual's life. This condition may develop as a result tests, graft-mediated recovery, LID, and GID can be tested experimenof physical trauma, disease processes (e.g., diabetes), exposure to tally in hemiparkinsonian rat models. However, there has been little drugs and chemical compounds, or infections (e.g., HIV) (Ossipov et translation to the mouse. Mice were unilaterally lesioned with 6al., 2011). Current treatments poorly control chronic pain and bring OHDA directed at the medial forebrain bundle and assessed on: only symptomatic relief to suffering people. They do not eliminate the rotarod, cylinder, corridor, balance beam, locomotor activity, psychocause of the condition or, in other words, they do not promote regenerstimulant, and spontaneous rotational behavior to determine levels of ation or rescue of damaged neurons. In addition, existing neuropathic dopamine depletion and to predict those that would develop LID, as pain treatment strategies are accompanied by the drug tolerance develseen by a dose escalation (2-25 mg/kg). 6-OHDA-lesioned mouse opment. Thus, the necessity to develop novel medications supporting models that displayed LID from two strains (C57/Bl6 and CD1) were injured neurons in patients with chronic pain is clear. It is well estabthen used for the transplantation of dissociated E14 VM tissue (correlished that neuronal cells require constant support for survival and sponding strain and crossover strains) and mouse epiblast-derived stem proper functioning that is provided by small secretory proteins called cells (EpiSCs) differentiated toward a dopaminergic phenotype, with neurotrophic factors. One of such proteins called artemin (ARTN) supthe aim of modeling GID driven by amphetamine (2.5 mg/kg). ports sensory neurons and, as was recently shown, is able to relieve Amphetamine-mediated GID has so far only been demonstrated in the symptoms and repair damaged neurons in animal models of neurorat using rat primary tissue. Rotarod, apomorphine-induced rotations, pathic pain (Gardell et al., 2003; Wang et al., 2008) . Thus, ARTN can and locomotor activity were significantly correlated with the developpave the way to the development of a totally new approach for neuroment of LID, yet many more tests were correlated to dopamine deplepathic pain management. ARTN belongs to the glial cell line-derived tion. GID was induced in mice using primary tissue from the same neurotrophic factor (GDNF) family ligands (GFLs) and signals via a strain, different from those that were not strain matched or that receptor complex consisting of transmembrane rearranged during received EpiSCs. LID and GID mouse models may have wide implicatransfection (RET) receptor tyrosine kinase (RTK) and a co-receptortions for combined use with the transplantation of different mouse cell GDNF family receptor α3 (GFRα3). Ligand binding to GFRα3 leads lines and transgenic models in future experiments. to phosphorylation of RET, followed by subsequent activation of intracellular signaling cascades including MAPK (mitogen activated protein kinases), Src, and AKT (protein kinase B), which support the
Increased Interneuronal Activity Following High Cervical Spinal
onset. In the present study we compared high versus low passage nhUCBSCs to determine whether highly expanded nhUCBSCs are as Cord Injury in Adult Rats therapeutically effective as low passaged cells. Using the middle cerebral arterial occlusion (MCAO) model of stroke in Sprague-Dawley V. M. Spruance, E. J. Gonzalez-Rothi, B. E. O'Steen, D. D. Fuller, rats, we administered nhUCBSCs by intravenous administration 2 days M. A. Lane, and P. J. Reier following stroke induction. These human cells were injected into rats without any immune suppression, but no adverse reactions were Department of Neuroscience, College of Medicine and McKnight detected. Both behavioral and histological analyses have shown that Brain Institute, University of Florida, Gainesville, FL, USA the administration of these cells reduces the infarct volume by 50% as Injury in cervical spinal cord frequently impairs respiratory funcwell as improves the functional outcome of these rats following stroke tion with the greatest deficits arising from direct damage to the phrenic for both high and low passaged nhUCBSCs. Staining for donor cells circuit and diaphragm paresis/paralysis. It is known from experimental using antibodies that recognize human nuclei in the rat brains have studies using a lateral C2 hemisection (C2Hx) in the adult rat, howshown that the injected cells are not present 5 days following injection. ever, that spontaneous recovery of diaphragm function can occur.
We believe the therapeutic effect of these cells is not due to any Recent experiments have identified cervical interneurons that could engraftment in the host brain, but rather that these cells provide a contribute to respiratory neuroplasticity following lateralized hemisecprofile of secreted cytokines/growth factors that help combat a chronic tion lesions at C2 (i.e., C2Hx). However, prephrenic interneuron activinflammatory response that follows stroke. Our results demonstrate ity following C2Hx is not well defined. In fact, little is known about that high passaged nhUCBSCs are as effective therapeutically as low the change in activity within spinal neurons following injuries at this passaged cells. As a consequence high passaged nhUCBSCs can serve level. The present study aims to address this gap in knowledge. Activas an abundant source of cells for the treatment of ischemic brain ity of cervical interneurons and motoneurons in the normal (naive) injury. Moreover, the therapeutic benefits can be achieved without the adult rat spinal cord was examined using immunocytochemical assessneed of immunosuppressive agents. nhUCBSCs have great potential ment of c-fos expression. These results were compared against i) naive to provide a novel therapy for stroke with no known ill-effects, and animals exposed to a respiratory challenge (10 min of hypoxia) and are effective at later time points following stroke than methods that ii) animals 2 weeks following C2Hx. All animals were euthanized at are currently available in the clinic. the same time of day under the same conditions. Transynaptic tracing with pseudorabies virus (PRV) applied to the ipsilateral hemidia-Traumatic Brain Injury Expedites ␤-Amyloid Accumulations phragm was used in a subset of animals to label phrenic motoneurons in the Cortex and Hippocampus of Alzheimer's Disease and prephrenic interneurons ipsi-or contralateral to injury. Very lim-Transgenic Mice ited c-fos expression was seen in the cervical cords of naive animals. Following exposure to hypoxia, however, there was a slight increase N. Tajiri,* L. E. Glover,* T. Shimizu, † G. W. Arendash, ‡ in motoneuron c-fos staining in the region of the phrenic nucleus, as and C. V. Borlongan* well as interneuronal labeling in laminae VII and X. This pattern was consistent with PRV first-and second-order labeling. An even greater *Center of Excellence for Aging and Brain Repair, Department increase in c-fos-positive motoneurons and interneurons was observed of Neurosurgery and Brain Repair, University of South Florida 2 weeks post-C2Hx. While there was a moderate increase in c-fos in Morsani College of Medicine, Tampa, FL, USA laminae VII and X, there was an even greater increase in the dorsal †Department of Psychology, University of South Florida, horns both above and below the injury level. Immunocytochemistry Tampa, FL, USA for neuronal and astrocytic markers confirmed that c-fos expression ‡Department of Cell Biology, Microbiology, & Molecular was limited to neurons. Studies are under way to electrophysiologi-Biology, College of Arts and Science, University of South Florida, cally record neuronal activity from identified regions in naive and Tampa, FL, USA injured animals. These results are consistent with initial electrophysio-Traumatic brain injury (TBI) has become a signature wound of logical recordings showing cervical interneurons that are responsive to the war in Iraq and Afghanistan. Many American soldiers, even those hypoxia and may thus be responsive to conditions requiring increased undiagnosed but likely suffering from mild TBI, display Alzheimer's respiratory drive and phrenic motoneuron output. disease (AD)-like cognitive impairments, suggesting a pathological Supported by NIH RO1 NS054025 (P.J.R.), the Anne and Oscar overlap between TBI and AD. This study examined the possible mech-Lackner Chair in Medicine (P.J.R.), and the Paralyzed Veterans of anistic link between TBI and AD by characterizing the histological America (M.A.L.). effects of TBI in presymptomatic amyloid precursor protein/presenilin 1 (APP/PS1) AD-transgenic (tg) mice. These AD-tg mice display AD-Intravenous Administration of High and Low Passaged like behavioral deficits by 15-17 months of age and AD-like neuropa-Nonhematopoietic Human Umbilical Cord Blood Stem Cells thology as early as 6 months of age. To reveal the effects of TBI on (nhUCBSC) as a Novel Therapy for Ischemic Stroke the AD-tg mice, the present study began at age 3 months and ended at age 5 months. Nontransgenic (non-tg) mice served as the control L. Stone,* † C. Nan,* M. Ritchie,* F. Xiao,* M. Donatelle,* ‡ group. There were four treatment groups: AD transgenic mice + TBI G. Larson,* E. Leathly,* † S. Greimel,* † and W. Low* † (n = 8), AD transgenic mice + sham surgery (n = 8), nontransgenic mice + TBI (n = 7), and nontransgenic mice + sham surgery (n = 7). *Department of Neurosurgery, University of Minnesota, AD-tg mice and non-tg mice received an experimental TBI at the right Minneapolis, MN, USA parietal cortex using the controlled cortical impact (CCI) model. β- †Graduate Program in Neuroscience, University of Minnesota, Amyloid (Aβ) was significantly increased by at least eight times in Minneapolis, MN, USA the cortex of AD-tg mice that received TBI compared to the non-tg ‡College of St. Catherine, University of Minnesota, mice that received TBI and the AD-tg and non-tg mice that underwent Minneapolis, MN, USA sham surgery. A significant decrease in microtubule associated protein 2 (MAP2)-positive cells was observed in the cortex of both the AD-Despite the high prevalence and devastating outcome of ischemic stroke, there remain few options for treatment following stroke onset.
tg and non-tg mice that received TBI compared to the AD-tg and nontg mice subjected to sham surgery. Similarly, there was a significant The treatments that are currently available remain limited in the time window following stroke in which they are effective and in their suc-increase in Aβ accumulations by at least 10 times in the hippocampus of the AD-tg mice that received TBI compared to all other groups. cess in ameliorating stroke injury in the brain as well as functional outcome. Current therapies for stroke, such as tissue plasminogen acti-Conversely, there was significant decrease in MAP2-positive cells in the hippocampus of the AD-tg mice that underwent TBI surgery com-vator (tPA), are only effective up to 18 h following stroke onset. We have tested a novel stroke therapy that has shown a significant reduc-pared to the non-tg mice that received sham surgery. These results suggest that TBI may precipitate AD-like pathology in presymptom-tion in stroke infarct volume as well as improved functional recovery following stroke in the rat when administered 48 h following stroke atic AD-tg mice. A recent article (Tran et al., J. Neurosci., 2011)
